| Note |
Name of Cell |
Registry No. |
Animal |
Tissue |
Description |
More Info at JCRB site |
|---|
|
0-9 |
Page Top |
|
|
|
|
|
104C1 |
JCRB9036 |
guinea pig |
fetal body
|
fetal carcass, benzo(a)pyrene transformed, diploid
|
more |
|
16-8 |
JCRB0013 |
mouse |
antibody-producing hybridoma
|
anti-human erythrocyte, IgM
|
more |
|
19-7 |
JCRB0014 |
mouse |
antibody-producing hybridoma
|
anti-human erythrocyte, IgM
|
more |
|
293 |
JCRB9068 |
human |
kidney
|
transformed embryonal kidney by adenovirus (type5)
|
more |
|
3LL |
JCRB1348 |
mouse |
lung
|
Lewis lung cancer-derived cell line, (C57BL mouse)
|
more |
|
3'-mRLh-2 |
JCRB0431 |
rat |
liver
|
hepatoma, (Donryu rat)
|
more |
|
3'-mRLN-30 |
JCRB0421 |
rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
more |
|
3'-mRLN-31 |
JCRB0422 |
rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
more |
|
3T3 L1 |
JCRB9014 |
mouse |
embryo
|
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
|
more |
|
3T3-L1 |
IFO50416 |
mouse |
embryo
|
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
|
more |
|
3T3-Swiss albino |
IFO50417 |
mouse |
embryo
|
fibroblast, contact inhibited, (Swiss albino mouse)
|
more |
|
3T3-Swiss albino |
JCRB9019 |
mouse |
embryo
|
fibroblast, contact inhibited, (Swiss albino mouse)
|
more |
|
3T6-Swiss albino |
JCRB9059 |
mouse |
embryo
|
fibroblast, collagen-secreting, (Swiss albino mouse)
|
more |
|
3Y1-B Clone 1-6 |
JCRB0734 |
rat |
embryo
|
fibroblast, whole embryo, (Fischer 344 rat)
|
more |
|
4-2D |
JCRB0084 |
mouse |
antibody-producing hybridoma
|
anti-primase complexed with DNA polymerase alpha
|
more |
|
4-8H |
JCRB0083 |
mouse |
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
|
more |
|
4G12 hybridoma |
IFO50090 |
mouse x human |
antibody-producing hybridoma
|
4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
|
more |
|
5RP7 |
IFO50277 |
rat |
embryo
|
fibroblast transformed by c-Ha-ras oncogene
|
more |
|
6-23 clone 6 |
IFO50270 |
rat |
thyroid
|
medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
|
more |
|
77N1 |
IFO50280 |
rat |
kidney
|
transformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat)
|
more |
|
7D4 |
JCRB9092 |
mouse x rat |
antibody-producing hybridoma
|
anti-murine IL-2 receptors (rat antibody)
|
more |
|
8305C |
JCRB0824 |
human |
thyroid
|
thyroid anaplastic carcinoma, undifferentiated
|
more |
|
8505C |
JCRB0826 |
human |
thyroid
|
thyroid carcinoma, undifferentiated
|
more |
|
9-15c |
JCRB1181 |
mouse |
bone marrow
|
mesenchymal cell line
|
more |
|
A |
Page Top |
|
|
|
|
|
A1 |
IFO50519 |
mouse |
neural
|
derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
|
more |
|
A-172 |
JCRB0228 |
human |
neural
|
glioblastoma
|
more |
|
A2058 |
IFO50276 |
human |
melanoma
|
malignant melanoma, metastasis to lymph node
|
more |
|
A2B5 clone 105 |
IFO50284 |
mouse |
antibody-producing hybridoma
|
A2B5 antibody, recognizing a glycolipid expressed in neural tissue
|
more |
|
A3/KAW |
JCRB0101 |
human |
hemo-lymphocytic
|
lymphoma, malignant
|
more |
|
A31-1-1 |
JCRB1356 |
mouse |
embryo
|
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
|
more |
|
A31-714 C4 |
IFO50021 |
mouse |
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
|
more |
|
A4/Fuk |
JCRB0097 |
human |
hemo-lymphocytic
|
lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
|
more |
|
A-431 |
IFO50411 |
human |
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF receptor
|
more |
|
A-431 |
JCRB0004 |
human |
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF-receptor
|
more |
|
A-431 |
JCRB9009 |
human |
epidermoid carcinoma
|
epidermoid carcinoma, high expression of EGF-receptor
|
more |
|
A549 |
IFO50153 |
human |
lung (cancer)
|
adenocarcinoma
|
more |
|
A549 |
JCRB0076 |
human |
lung (cancer)
|
adenocarcinoma
|
more |
|
A9 |
JCRB0211 |
mouse |
skin
|
skin fibroblast, 8-azaguanine-resistant, (C3H mouse)
|
more |
|
A9(0439)-1 |
JCRB0732 |
human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome Xpter>Xq26::3p12>3pter
|
more |
|
A9(2621)-4 |
JCRB0730 |
human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 12pter>12q24::Xq22>Xqter
|
more |
|
A9(3552)-2 |
JCRB0731 |
human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 11pter>11q23::Xq26>Xqter
|
more |
|
A9(3884)-1 |
JCRB0729 |
human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 16pter>16q24::Xq26>Xqter
|
more |
|
A9(7151)-3 |
JCRB0728 |
human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome 17pter>17q11::Xq11>Xqter
|
more |
|
A9(An4)-2 |
JCRB0727 |
human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome # 1
|
more |
|
A9(Bsr10) |
JCRB2210 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #10
|
more |
|
A9(BsrX) |
JCRB2223 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome X
|
more |
| *8) |
A9(Hygro13) |
JCRB2213 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #13
|
more |
| *8) |
A9(Hygro14) |
JCRB2214 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #14
|
more |
| *8) |
A9(Hygro21) |
JCRB2221 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #21
|
more |
| *8) |
A9(Hygro22) |
JCRB2222 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #22
|
more |
|
A9(Neo1) |
JCRB2201 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 1
|
more |
|
A9(neo11) |
JCRB2211 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #11
|
more |
|
A9(Neo12) |
JCRB2212 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #12
|
more |
|
A9(Neo15) |
JCRB2215 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #15
|
more |
|
A9(Neo16) |
JCRB2216 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #16
|
more |
| *8) |
A9(Neo17) |
JCRB2217 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #17
|
more |
|
A9(Neo18) |
JCRB2218 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #18
|
more |
|
A9(Neo19) |
JCRB2219 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #19
|
more |
|
A9(Neo2) |
JCRB2202 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 2
|
more |
|
A9(Neo20) |
JCRB2220 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome #20
|
more |
|
A9(Neo3) |
JCRB2203 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 3
|
more |
|
A9(Neo4) |
JCRB2204 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 4
|
more |
|
A9(Neo5) |
JCRB2205 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 5
|
more |
|
A9(Neo6) |
JCRB2206 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 6
|
more |
|
A9(Neo7) |
JCRB2207 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 7
|
more |
|
A9(Neo8) |
JCRB2208 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 8
|
more |
|
A9(NTI8)-2 |
JCRB0726 |
human chromosome-introduced |
human chromosomal hybrid
|
contains human chromosome # 7
|
more |
|
ABC-1 |
JCRB0815 |
human |
lung (cancer)
|
adenocarcinoma
|
more |
|
Ac2F |
JCRB0408 |
rat |
liver
|
normal liver, diploid, (Donryu rat)
|
more |
|
Ac2F(DT) |
JCRB0416 |
rat |
liver
|
Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
|
more |
|
Ac2F(ST) |
JCRB0417 |
rat |
liver
|
Ac2F-derived, spontaneously transformed, (Donryu rat)
|
more |
|
Ad12-3Y1-Z19 |
JCRB0737 |
rat |
embryo
|
3Y1 derivative, Ad12-transformed, (Fischer rat)
|
more |
|
AH601(JTC27) |
JCRB0132.1 |
rat |
liver
|
transplantable ascites hepatoma, (Donryu rat)
|
more |
|
AH601.P3(JTC27) |
JCRB0132.2 |
rat |
liver
|
transplantable ascites hepatoma, serum-free, (Donryu rat)
|
more |
|
AH601.P3(JTC27) |
JCRB0132.3 |
rat |
liver
|
transplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat)
|
more |
|
AH66tc |
JCRB0411 |
rat |
liver
|
ascites hepatoma, (Donryu rat)
|
more |
|
AH70Btc |
JCRB0412 |
rat |
liver
|
ascites hepatoma, (Donryu rat)
|
more |
|
AH-7974.P3 |
JCRB0714.1 |
rat |
liver
|
ascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat)
|
more |
|
AIG |
JCRB1105 |
hamster, Chinese |
lung
|
anchorage-independent mutant of CHL
|
more |
|
Alexander cells |
IFO50069 |
human |
liver, gallbladder
|
hepatoma, HBs antigen-positive
|
more |
|
AM-38 |
IFO50492 |
human |
neural
|
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
|
more |
|
AP-16 |
IFO50424 |
mouse |
neural
|
astrocyte-progenitor cell line, (C3H/He mouse)
|
more |
|
AR-EcoScreen |
JCRB1328 |
hamster, Chinese |
ovary
|
androgen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required)
|
more |
|
ARLJ301-3 |
JCRB0248 |
rat |
liver
|
liver epithelial cell, (F344/DuCrj rat)
|
more |
|
ASF-4-1 |
IFO50418 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
ASF-4-2 |
IFO50419 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
ASH-3 |
JCRB1073 |
human |
thyroid
|
thyroid anaplastic carcinoma
|
more |
| *2) |
AT(L)5KY |
JCRB0331 |
human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
|
more |
| *2) |
AT(L)6KY |
JCRB0332 |
human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
|
more |
| *2) |
AT(L)7KY |
JCRB0333 |
human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
|
more |
| *2) |
AT1OS |
JCRB0308 |
human |
skin
|
ataxia telangiectasia, fibroblast
|
more |
| *2) |
AT2KY |
JCRB0316 |
human |
skin
|
ataxia telangiectasia, fibroblast
|
more |
|
AtT-20 |
JCRB9098 |
mouse |
pituitary
|
pituitary tumor, ACTH producing, (LAF1 mouse)
|
more |
|
AZ-521 |
JCRB0061 |
human |
stomach
|
originally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80
|
more |
|
B |
Page Top |
|
|
|
|
|
B-1 |
JCRB0243 |
mouse |
testis
|
Leydig cell tumor, estrogen-dependent, (BALB/c mouse)
|
more |
|
B104 |
JCRB0117 |
human |
hemo-lymphocytic
|
lymphoma, malignant B lymphoma
|
more |
| *1) |
B104-R3 |
JCRB0117.1 |
human |
hemo-lymphocytic
|
lymphoma, malignant B lymphoma, anti-IgM antibody resistant B104
|
more |
|
B16 melanoma |
JCRB0202 |
mouse |
melanoma
|
melanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse)
|
more |
|
B2-17 |
IFO50361 |
human |
neural
|
astrocytoma, thymidine kinase-deficient mutant of U251 MG cells
|
more |
|
B8/3 |
JCRB0238 |
mouse |
hemo-lymphocytic
|
erythroleukemia
|
more |
|
B82 |
JCRB0212 |
mouse |
skin
|
skin fibroblast, bromodeoxyuridine-resistant
|
more |
|
B95-8 |
JCRB9123 |
cotten-top tamarin |
hemo-lymphocytic
|
EBV transformed, release EBV infectious to primates
|
more |
|
BALB/3T3 A31-1-1 |
JCRB0601 |
mouse |
embryo
|
fibroblast, contact inhibited, (BALB/c mouse)
|
more |
|
BALB/3T3 clone A31 |
JCRB9005 |
mouse |
embryo
|
fibroblast, contact inhibited, (BALB/c mouse)
|
more |
|
Balb/3T3-A31-1-1 |
IFO50070 |
mouse |
embryo
|
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
|
more |
|
Balb/c 3T3 A31-1-13 |
IFO50299 |
mouse |
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
|
more |
|
Balb/c 3T3 A31-I-1 |
IFO50298 |
mouse |
embryo
|
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
|
more |
|
BALB-MC |
JCRB0233.0 |
mouse |
mammary
|
mammary cancer, (BALB/cHe mouse)
|
more |
|
BALB-MC.D3 |
JCRB0233.1 |
mouse |
mammary
|
mammary cancer, (BALB/cHe mouse)
|
more |
|
BALB-MC.E12 |
JCRB0233.2 |
mouse |
mammary
|
mammary cancer, (BALB/cHe mouse)
|
more |
|
BALL-1 |
JCRB0071 |
human |
hemo-lymphocytic
|
leukemia, acute lymphoblastoid
|
more |
|
BCE C/D-1b |
JCRB9129 |
bovine |
cornea
|
normal corneal epithelial cell, production of extracellular matrix proteins
|
more |
|
BCL1 Clone CW13.20 |
JCRB9117 |
mouse |
hemo-lymphocytic
|
leukemia, B cell, (BALB/c mouse)
|
more |
| *2) |
BCNS1KO |
JCRB0324 |
human |
skin
|
basal cell nevus syndrome, fibroblasts
|
more |
|
Becker |
IFO50289 |
human |
neural
|
astrocytoma, GFAP-negative
|
more |
|
BeWo |
JCRB9111 |
human |
placenta
|
chorio carcinoma, trophoblastic cell line
|
more |
|
Bhas 42 |
JCRB0149 |
mouse |
embryo
|
H-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse)
|
more |
|
BHK-21(C-13) |
JCRB9020 |
hamster, Syrian |
kidney
|
kidney, subclone of BHK-21
|
more |
|
BOKU |
IFO50323 |
human |
uterine cervix
|
cervical squamous cell carcinoma
|
more |
|
BRL-3A |
JCRB0025 |
rat |
liver
|
MSA (somatomedin-like) protein producing, (Buffalo rat)
|
more |
|
BRL-3A |
JCRB9114 |
rat |
liver
|
MSA (somatomedin-like) protein producing, (Buffalo rat)
|
more |
| *2) |
BS2CH |
JCRB0317 |
human |
skin
|
Bloom's syndrome, fibroblast
|
more |
|
BS2CHTERT |
JCRB1061 |
human |
skin
|
Bloom's syndrome, fibroblast, immortalized by hTERT
|
more |
|
BS-C-1 |
IFO50413 |
monkey, African green |
kidney
|
suitable host for transfection experiments of SV40 vectors
|
more |
| *1) |
BS-C-1 |
JCRB9011 |
monkey, African green |
kidney
|
kidney
|
more |
|
BS-C-1 |
JCRB9126 |
monkey, African green |
kidney
|
suitable host for transfection experiments of SV40 vectors
|
more |
|
BSL2KA |
JCRB1042 |
human |
hemo-lymphocytic
|
EBV transformed B lymphoblastoid cell line from Bloom's syndrome patient
|
more |
|
BW5147.G.1.4.OUA-R.1 |
JCRB9002 |
mouse |
hemo-lymphocytic
|
lymphoma, T cell lymphoma, (AKR/J mouse)
|
more |
|
C |
Page Top |
|
|
|
|
|
C32TG |
JCRB0227 |
human |
melanoma
|
skin amelanotic melanoma, 6-thioguanine-resistant
|
more |
| *1) |
C3H/10T1/2 clone 8 |
JCRB0602 |
mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.)
|
more |
|
C3H/10T1/2 clone 8 |
JCRB9080 |
mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)
|
more |
|
C3H/10T1/2-clone 8 |
JCRB0003 |
mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)
|
more |
|
C3H/10T1/2-clone8 |
IFO50415 |
mouse |
embryo
|
fibroblast, contact inhibited, (C3H mouse)
|
more |
|
C3H/MCA clone 15 |
IFO50042 |
mouse |
embryo
|
3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse)
|
more |
|
C6 |
IFO50110 |
rat |
neural
|
glial tumor, GFAP-positive
|
more |
|
C6 |
JCRB9096 |
rat |
neural
|
glial tumor, GFAP-positive
|
more |
|
C6/36 |
IFO50010 |
mosquito |
hatched larvae
|
useful for replication of flavivirus
|
more |
|
C6-SF2 |
IFO50425 |
rat |
neural
|
C6 subline adapted to serum-free medium
|
more |
|
Ca Ski |
IFO50007 |
human |
uterine cervix
|
cervical epidermoid cancer
|
more |
|
Ca9-22 |
JCRB0625 |
human |
oral
|
squamous carcinoma, gingiva
|
more |
|
Caki-1 |
JCRB0801 |
human |
kidney
|
renal clear cell carcinoma
|
more |
|
CaR-1 |
JCRB0207 |
human |
rectum
|
adenocarcinoma
|
more |
| *1) |
CCD 841 CoN |
IFO50482 |
human |
colon
|
established from normal colonic tissue, epithelial-like, (distribution finished)
|
more |
|
CCD-14Br |
JCRB9101 |
human |
lung
|
bronchus, diploid
|
more |
|
CCD-33Co |
IFO50483 |
human |
colon
|
established from normal colon, fibroblast, (the lot in cellbank does not grow)
|
more |
|
CCK-81 |
JCRB0208 |
human |
colon
|
adenocarcinoma
|
more |
|
CCRF S-180 II |
JCRB9089 |
mouse |
sarcoma
|
S-180 sarcoma derivative
|
more |
|
CCRF-CEM |
IFO50412 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
CCRF-CEM |
JCRB0033 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
CCRF-CEM |
JCRB9023 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
CCRF-HSB2 |
JCRB0031 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
CCRF-SB |
IFO50026 |
human |
hemo-lymphocytic
|
leukemia, acute B lymphoblastic
|
more |
|
CCRF-SB |
JCRB0032 |
human |
hemo-lymphocytic
|
leukemia, acute B lymphoblastic
|
more |
|
Ch 1 Es |
JCRB9037 |
goat |
esophagus
|
esophagus
|
more |
|
Chang Liver |
IFO50016 |
human |
HeLa-contaminant
|
originally established from liver, HeLa-contaminated
|
more |
|
Chang Liver |
JCRB9066 |
human |
HeLa-contaminant
|
originally established from liver, HeLa-contaminated
|
more |
|
CHL/IU |
JCRB0030 |
hamster, Chinese |
lung
|
normal
|
more |
| *8) |
CHO(His9) |
JCRB2209 |
human chromosome-introduced |
human monochromosomal hybrid panel
|
contains human chromosome # 9
|
more |
|
CHO(pMAM-HSluc) |
JCRB0136.2 |
hamster, Chinese |
ovary
|
pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
|
more |
|
CHO(pMAM-luc) |
JCRB0136.1 |
hamster, Chinese |
ovary
|
pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
|
more |
|
CHO/HGPRT |
JCRB0218 |
hamster, Chinese |
ovary
|
HPRT-deficient CHO cell line
|
more |
|
CHO-K1 |
IFO50414 |
hamster, Chinese |
ovary
|
subclone of CHO (Chainese hamster ovary) cells
|
more |
|
CHO-K1 |
JCRB9018 |
hamster, Chinese |
ovary
|
subclone of CHO (Chainese hamster ovary) cells
|
more |
|
CKT-1 |
IFO50003 |
bovine |
kidney
|
useful to assay bovine adenovirus 3
|
more |
|
CKT-1 |
JCRB0008 |
bovine |
kidney
|
useful to assay bovine adenovirus 3
|
more |
|
CMK-11-5 |
IFO50430 |
human |
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
|
more |
|
CMK-86 |
IFO50428 |
human |
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
|
more |
|
CoCM-1 |
JCRB0257 |
human |
colon
|
adenocarcinoma
|
more |
|
COLO201 |
JCRB0226 |
human |
colon
|
adenocarcinoma
|
more |
|
COLO320 DM |
JCRB0225 |
human |
colon
|
adenocarcinoma
|
more |
|
COS-1 |
JCRB9082 |
monkey, African green |
kidney
|
SV40 transformed African green monkey kidney
|
more |
|
COS-7 |
IFO50068 |
monkey, African green |
kidney
|
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
|
more |
|
COS-7 |
JCRB9127 |
monkey, African green |
kidney
|
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
|
more |
| *1) |
CPA |
IFO50272 |
bovine |
vascular system
|
pulmonary artery normal endothelial cell
|
more |
|
CPA |
JCRB9025 |
bovine |
vascular system
|
pulmonary artery normal endothelial cell
|
more |
|
CPAE |
JCRB9022 |
bovine |
vascular system
|
pulmonary artery normal endothelial cell
|
more |
|
CPT-K5 |
JCRB1067 |
human |
hemo-lymphocytic
|
leukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402
|
more |
|
CRFK |
JCRB9035 |
cat |
kidney
|
kidney, BVD antigen negative
|
more |
|
cs-17-25 |
JCRB1102 |
hamster, Chinese |
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
|
more |
|
cs-19-36 |
JCRB1103 |
hamster, Chinese |
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
|
more |
|
cs-20-5 |
JCRB1104 |
hamster, Chinese |
lung
|
cold-sensitive anchorage-independent growth mutant of CHL
|
more |
| *2) |
CS2AW |
JCRB0310 |
human |
skin
|
Cockayne's syndrome, fibroblast
|
more |
|
CS2AWTERT |
JCRB1059 |
human |
skin
|
Cockayne's syndrome, fibroblast, immortalized by hTERT
|
more |
| *2) |
CS2OS |
JCRB0309 |
human |
skin
|
Cockayne's syndrome, fibroblast
|
more |
|
CS2OS(SVT) |
JCRB1056 |
human |
skin
|
Cockayne's syndrome, fibroblast, immortalized by SV40 large T
|
more |
|
CV-1 |
JCRB9049 |
monkey, African green |
kidney
|
kidney, highly susceptible to SV40 infection
|
more |
|
c-WRT-7-LR |
JCRB0168 |
rat |
hemo-lymphocytic
|
RLV infected myelomonocytic leukemia.
|
more |
|
D |
Page Top |
|
|
|
|
| *1) |
D422T |
JCRB9112 |
human |
sarcoma
|
benign abdominal desmoid tumor
|
more |
|
Daudi |
JCRB9071 |
human |
hemo-lymphocytic
|
lymphoma, Burkitt's
|
more |
|
DBC1.2 |
IFO50484 |
mouse |
olfactory epithelium
|
dark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse)
|
more |
|
DD-762 |
JCRB1077 |
mouse |
mammary
|
mammary tumor, producing MuMTV, (DD/Tbr mouse)
|
more |
|
De Gin |
JCRB9078 |
human |
skin
|
osteoporosis, skin
|
more |
|
delta-47 |
JCRB1344 |
human |
hemo-lymphocytic
|
myeloma, secreting IgD
|
more |
| *1) |
Dempsey |
JCRB9088 |
human |
skin
|
Klinefelter's syndrome, skin
|
more |
|
Detroit 510 |
JCRB9104 |
human |
skin
|
galactosemia, skin
|
more |
|
Detroit 525 |
JCRB9102 |
human |
skin
|
Turner's syndrome, skin
|
more |
| *1) |
Detroit 529 |
JCRB9043 |
human |
skin
|
Down's syndrome, skin
|
more |
|
Detroit 532 |
JCRB9044 |
human |
skin
|
Down's syndrome, foreskin
|
more |
|
Detroit 539 |
JCRB9045 |
human |
skin
|
Down's syndrome, skin
|
more |
|
DIG104.10H.1 |
JCRB1213.3 |
mouse |
antibody-producing hybridoma
|
anti-digoxin antibody, subclass IgG1(k)
|
more |
|
DIG222.4D.5 |
JCRB1213.2 |
mouse |
antibody-producing hybridoma
|
anti-digoxin antibody, subclass IgG2b(k)
|
more |
|
DL-40 |
JCRB1337 |
human |
hemo-lymphocytic
|
lymphoma, non-Hodikin's, Ki-1-positive
|
more |
|
DLD-1 |
JCRB9094 |
human |
colon
|
adenocarcinoma
|
more |
|
dRLa-74 Clone 2 |
JCRB0409 |
rat |
liver
|
liver adenoma, (Donryu rat)
|
more |
|
dRLh-84 |
JCRB0410 |
rat |
liver
|
hepatoma, (Donryu rat)
|
more |
|
dRLN-4 |
JCRB0418 |
rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
more |
|
dRLN-6 |
JCRB0420 |
rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
more |
|
dRLN-9 |
JCRB0419 |
rat |
liver
|
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
|
more |
|
DSPT200 |
JCRB0217 |
hamster, Syrian |
embryo
|
fetus fibroblast transformed cell
|
more |
|
DT40 |
JCRB9130 |
chicken |
hemo-lymphocytic
|
avian leukosis virus (ALV)-induced lymphomas
|
more |
|
E |
Page Top |
|
|
|
|
|
E1A-3Y1-1 |
JCRB0738 |
rat |
embryo
|
3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
|
more |
| *1) |
EB-3 |
IFO50028 |
human |
hemo-lymphocytic
|
eliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line)
|
more |
|
EBC-1 |
JCRB0820 |
human |
lung (cancer)
|
squamous cell carcinoma
|
more |
|
EBTr (NBL-4) |
JCRB9038 |
bovine |
lung
|
embryonic trachea
|
more |
| *5) |
ECV304 |
JCRB0744 |
human |
vascular system
|
immortalized normal endothelium, contamination by T-24/EJ1 was suspected.
|
more |
|
EGV-4T |
JCRB0229 |
rat |
lung
|
immortal cell line from MNNG-transformed tracheal epithelial cells
|
more |
|
Ehrlich ascites |
JCRB9090 |
mouse |
ascites
|
Ehrlich-Lettre ascites carcinoma
|
more |
|
EHS |
IFO50268 |
mouse |
sarcoma
|
chondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse)
|
more |
|
EJ-1 |
JCRB0710 |
human |
bladder
|
bladder carcinoma, contamination by T24 cells has been suspected
|
more |
|
Ex-3LL |
JCRB1349 |
mouse |
lung
|
Lewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse)
|
more |
|
F |
Page Top |
|
|
|
|
|
F119 |
JCRB1324 |
mouse |
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b
|
more |
|
F2408 |
IFO50015 |
rat |
embryo
|
fibroblast-like, (Fischer rat)
|
more |
|
F2408 EBNA2 cl-14 |
JCRB0143.5 |
rat |
embryo
|
EBNA2-transfected, (Fischer rat)
|
more |
|
F2408 EBNA2 cl-16 |
JCRB0143.2 |
rat |
embryo
|
EBNA2-transfected, (Fischer rat)
|
more |
|
F2408 EBNA2 cl-18 |
JCRB0143.3 |
rat |
embryo
|
EBNA2-transfected, (Fischer rat)
|
more |
|
F2408 EBNA2 cl-23 |
JCRB0143.6 |
rat |
embryo
|
EBNA2-transfected, (Fischer rat)
|
more |
|
F2408 EBNA2 cl-24 |
JCRB0143.4 |
rat |
embryo
|
EBNA2-transfected, (Fischer rat)
|
more |
|
F2408 EBNA2 cl-28 |
JCRB0143.7 |
rat |
embryo
|
EBNA2-transfected, (Fischer rat)
|
more |
|
F2408 EBNA2 cl-9 |
JCRB0143.1 |
rat |
embryo
|
EBNA2-transfected, (Fischer rat)
|
more |
|
F2408 pZipNeo |
JCRB0143.0 |
rat |
embryo
|
pZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat)
|
more |
|
F2408-B812 |
IFO50099 |
rat |
embryo
|
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
|
more |
|
F2408-B993 |
IFO50100 |
rat |
embryo
|
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
|
more |
|
F2408-No.20 |
IFO50101 |
rat |
embryo
|
thymidine kinase-deficient F2408 cell line, (Fischer rat)
|
more |
|
F2408-No.3 |
IFO50098 |
rat |
embryo
|
HGPRT-deficient F2408 cell line, (Fischer rat)
|
more |
|
F2408-No.7 |
IFO50102 |
rat |
embryo
|
HGPRT-deficient F2408 cell line, (Fischer rat)
|
more |
|
F25 |
JCRB1323 |
mouse |
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a
|
more |
|
F56 |
JCRB1189 |
mouse |
antibody-producing hybridoma
|
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG1
|
more |
|
F9 |
JCRB0721 |
mouse |
teratoma
|
teratocarcinoma, differentiation-inducible, (129/Sv mouse)
|
more |
|
F9-41 |
JCRB0001 |
mouse |
teratoma
|
teratocarcinoma, differentiation-inducible, (129/Sv mouse)
|
more |
| *2) |
FA18JTO |
JCRB0315 |
human |
skin
|
Fanconi's anemia, fibroblast
|
more |
| *2) |
FA9JTO |
JCRB0314 |
human |
skin
|
Fanconi's anemia, fibroblast
|
more |
|
FA9JTOTERT |
JCRB1060 |
human |
skin
|
Fanconi's anemia, fibroblast, immortalized by hTERT
|
more |
|
FAA-HTC1 |
JCRB0249 |
rat |
liver
|
hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
|
more |
|
FBHE |
IFO50154 |
bovine |
vascular system
|
heart normal endothelial cell, FGF-dependent for survival
|
more |
|
FF101 |
JCRB1040 |
rat |
liver
|
hepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat)
|
more |
|
FHs 74 Int |
JCRB9076 |
human |
intestine
|
fetal small intestine, normal, (not intestinal epithelial cell)
|
more |
| *1) |
FL* |
JCRB9016 |
human |
HeLa-contaminant
|
originally established from amnion, HeLa-contaminated
|
more |
|
FLAM-76 |
JCRB1346 |
human |
hemo-lymphocytic
|
myeloma, IL-6-dependent, growth is very slow
|
more |
|
Flow2000 |
IFO50089 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
| *1) |
Flow2000 |
JCRB0067 |
human |
lung
|
fetal lung, normal diploid fibroblast (not available)
|
more |
|
Flow3000 |
JCRB0068 |
human |
neural
|
normal fibroblast
|
more |
|
Flow7000 |
IFO50079 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
FLS3 |
IFO50377 |
mouse |
liver
|
liver stromal cell line
|
more |
|
FLS5 |
IFO50378 |
mouse |
liver
|
liver stromal cell line
|
more |
|
FM3A |
JCRB0701 |
mouse |
mammary
|
mammary carcinoma, spontaneously obtained, (C3H/He mouse)
|
more |
|
FM3A APRT~ |
JCRB0703 |
mouse |
mammary
|
mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
|
more |
|
FM3A HPRT~ |
JCRB0702 |
mouse |
mammary
|
mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
|
more |
|
FM3A TK~ |
JCRB0704 |
mouse |
mammary
|
mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
|
more |
| *2) |
FPC15JTO |
JCRB0319 |
human |
skin
|
familial polyposis coli, fibroblasts
|
more |
| *2) |
FPC5JTO |
JCRB0318 |
human |
skin
|
familial polyposis coli, fibroblasts
|
more |
|
FRSK |
JCRB0005 |
rat |
skin
|
epidermal keratinocyte line from fetal skin
|
more |
|
FS-1 |
IFO50477 |
human |
bone marrow stroma
|
bone marrow stromal cell from a myelogenous leukemia patient
|
more |
|
FSthy21 |
JCRB0719 |
mouse |
thymidylate defective
|
complete defective strain of thymidylate synthase, (C3H mouse)
|
more |
|
FU97 |
JCRB1074 |
human |
stomach
|
adenocarcinoma, poorly differentiated, AFP producing
|
more |
|
G |
Page Top |
|
|
|
|
|
G-292 clone A141B1 |
IFO50107 |
human |
sarcoma
|
osteosarcoma
|
more |
|
G-361 |
IFO50009 |
human |
melanoma
|
malignant melanoma, skin
|
more |
|
G-361 |
JCRB9074 |
human |
melanoma
|
malignant melanoma, skin
|
more |
|
G-401 |
JCRB9065 |
human |
kidney
|
Wilms' tumor (embryonal carcinosarcoma of kidney)
|
more |
|
G-402 |
JCRB9070 |
human |
kidney
|
renal leiomyoblastoma
|
more |
|
GAK |
IFO50321 |
human |
melanoma
|
malignant melanoma at external genitalia, metastasis to lymph node
|
more |
|
GAK |
JCRB0180 |
human |
melanoma
|
malignant melanoma at external genitalia, metastasis to lymph node
|
more |
|
GB-1 |
IFO50489 |
human |
neural
|
glioma, GFAP, vimentin and fibronectin-positive
|
more |
|
GCH-nu-YS |
JCRB1201 |
human |
uterus
|
gestational uterine choriocarcinoma
|
more |
|
GH1 |
IFO50269 |
rat |
pituitary
|
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
|
more |
|
GH1 |
JCRB9046 |
rat |
pituitary
|
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
|
more |
|
GH3 |
IFO50105 |
rat |
pituitary
|
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
|
more |
|
GH3 |
JCRB9047 |
rat |
pituitary
|
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
|
more |
|
GHBP116 |
JCRB1226 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone receptor antibody-producing, subclass IgG1(k)
|
more |
|
GOTO |
JCRB0612 |
human |
neural
|
neuroblastoma, adrenal gland
|
more |
|
GOTO.P3 |
JCRB0612.1 |
human |
neural
|
neuroblastoma, adrenal gland, serum-free
|
more |
| *2) |
GP-1 |
JCRB1366 |
guinea pig |
hemo-lymphocytic
|
Guinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
|
GP8 |
JCRB1198 |
mouse |
skin
|
human beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
|
more |
|
GRSL |
IFO50111 |
mouse |
hemo-lymphocytic
|
thymic leukemia, (GR/A mouse)
|
more |
| *2) |
GS33JTO |
JCRB0322 |
human |
skin
|
Gardner's syndrome, fibroblasts, (M)
|
more |
| *2) |
GS7OJTO |
JCRB0323 |
human |
skin
|
Gardner's syndrome, fibroblasts
|
more |
|
H |
Page Top |
|
|
|
|
|
HARA |
JCRB1080.0 |
human |
lung (cancer)
|
squamous carcinoma, PTHrP producing
|
more |
|
HARA-B |
JCRB1080.1 |
human |
lung (cancer)
|
squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells
|
more |
|
HCA-1 |
JCRB1153 |
human |
uterine cervix
|
endocervical adenocarcinoma
endocervical adenocarcinoma cell line.
|
more |
|
HCC-56 |
JCRB1037 |
human |
colon
|
adenocarcinoma, moderately differentiated
|
more |
|
HCS-2 |
JCRB1203 |
human |
uterine cervix
|
cervical squamous cell carcinoma
|
more |
|
HCSC-1 |
JCRB1205 |
human |
uterine cervix
|
endocervical small cell carcinoma
|
more |
| *2) |
HCT-2 |
JCRB1362 |
hamster, Syrian |
hemo-lymphocytic
|
Hamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation).
|
more |
|
HD-70 |
JCRB1335 |
human |
hemo-lymphocytic
|
lymphoma, from Hodgkin's
|
more |
|
HE-1 |
IFO50297 |
human |
embryo
|
whole fetus, normal diploid fibroblast
|
more |
|
HEC-1 |
JCRB0042 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-108 |
JCRB1123 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-116 |
JCRB1124 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-151 |
JCRB1122 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
| *5) |
HEC-155 |
JCRB1127 |
human |
uterus
|
endometrial adenocarcinoma, (distribution was suspended)
|
more |
|
HEC-1-A |
JCRB1117 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-1-B |
JCRB1193 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-251 |
JCRB1141 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-265 |
JCRB1142 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-50B |
JCRB1145 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-59 |
JCRB1120 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-6 |
JCRB1118 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEC-88nu |
JCRB1121 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
HEL |
JCRB0062 |
human |
hemo-lymphocytic
|
leukemia, erythroid
|
more |
|
HeLa |
JCRB9004 |
human |
uterine cervix
|
epitheloid carcinoma
|
more |
|
HeLa 229 |
JCRB9086 |
human |
uterine cervix
|
epitheloid carcinoma
|
more |
|
HeLa AG |
JCRB0213 |
human |
uterine cervix
|
epitheloid carcinoma, 8-azaguanine-resistant
|
more |
|
HeLa S3 |
IFO50011 |
human |
uterine cervix
|
cervical epithelioid carcinoma
|
more |
|
HeLa S3 |
JCRB9010 |
human |
uterine cervix
|
cervical epitheloid carcinoma, adaptable to a suspension culture
|
more |
|
HeLa S3 (sc) |
JCRB0713 |
human |
uterine cervix
|
HeLa derivative, can grow in suspension culture
|
more |
|
HeLa TG |
JCRB0214 |
human |
uterine cervix
|
epitheloid carcinoma, 6-thioguanine-resistant
|
more |
|
HeLa TG Cap |
JCRB0215 |
human |
uterine cervix
|
epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
|
more |
|
HeLa.P3 |
JCRB0649 |
human |
uterine cervix
|
serum free adapted HeLa cell line
|
more |
|
HeLa.P3 |
JCRB0649.1 |
human |
uterine cervix
|
serum free adapted HeLa cell line, deposited by original developer
|
more |
|
HeLa.P3(S) |
JCRB0606 |
human |
uterine cervix
|
HeLa cell derived, can grow in a serum-free medium
|
more |
|
HeLa9903 |
JCRB1318 |
human |
uterine cervix
|
hERalpha-HeLa-9903, transfected with estrogen receptor-alpha - reporter gene construct. (MTA to developer is required)
|
more |
|
Hep G2 |
JCRB1054 |
human |
liver, gallbladder
|
hepatoma
|
more |
|
HEPM |
JCRB9095 |
human |
oral
|
embryonic palatal mesenchyme, limited life span
|
more |
|
HFb16d |
JCRB1008 |
human |
skin
|
normal fibroblast transfected with HPV16
|
more |
|
HFL1 |
IFO50074 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
|
HGH1.1.3 |
JCRB1222.01 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HGH1.11.1 |
JCRB1222.08 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
more |
|
HGH1.15.3 |
JCRB1222.09 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HGH1.17.2 |
JCRB1222.03 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HGH1.31.3 |
JCRB1222.12 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HGH1.32.4 |
JCRB1222.13 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
more |
|
HGH1.35.2 |
JCRB1222.04 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2a(k)
|
more |
|
HGH1.41.1 |
JCRB1222.10 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
more |
|
HGH1.46.1 |
JCRB1222.11 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
more |
|
HGH1.6.5 |
JCRB1222.02 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HGH1.8.1 |
JCRB1222.07 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG2b(k)
|
more |
|
HGH1.9.3 |
JCRB1222.06 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HGH2.15.4 |
JCRB1222.16 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(lambda)
|
more |
|
HGH2.4.2 |
JCRB1222.15 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HGH2.6.1 |
JCRB1222.05 |
mouse |
antibody-producing hybridoma
|
anti-human growth hormone antibody, subclass IgG1(k)
|
more |
|
HH |
JCRB0099 |
bovine |
vascular system
|
carotid artery normal endothelial cell
|
more |
|
HKA-1 |
JCRB1017 |
human |
skin
|
giant keratoacanthoma
|
more |
|
HL60 |
JCRB0085 |
human |
hemo-lymphocytic
|
leukemia, acute promyelotic, differentiation-inducible
|
more |
|
HL-60 |
IFO50022 |
human |
hemo-lymphocytic
|
leukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced
|
more |
|
HL60(S) |
JCRB0163 |
human |
hemo-lymphocytic
|
leukemia, acute promyelotic
|
more |
|
HL60RG |
JCRB0006 |
human |
hemo-lymphocytic
|
leukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced
|
more |
|
HLCL-1 |
JCRB0041 |
human |
hemo-lymphocytic
|
lymphocyte, peripheral
|
more |
|
HLE |
JCRB0404 |
human |
liver, gallbladder
|
hepatoma, non-differentiated
|
more |
|
HLF |
JCRB0405 |
human |
liver, gallbladder
|
hepatoma, non-differentiated
|
more |
|
HM-1 |
JCRB1208 |
hamster, Syrian |
hemo-lymphocytic
|
macrophage line
|
more |
|
HMC-1-8 |
JCRB0166 |
human |
mammary
|
breast cancer, target cell of the T-cell killer clone T(cHMC-1)
|
more |
|
HMY-1 |
JCRB1018 |
human |
melanoma
|
malignant melanoma, sole, melanin production is poor
|
more |
|
HO-1-N-1 |
JCRB0831 |
human |
oral
|
squamous carcinoma, buccal mucosa
|
more |
|
HO-1-u-1 |
JCRB0828 |
human |
oral
|
squamous carcinoma, mouth floor
|
more |
|
HOS |
IFO50106 |
human |
sarcoma
|
osteosarcoma
|
more |
|
HPSV178-4-3 |
JCRB1314 |
mouse |
antibody-producing hybridoma
|
HPSV178 antibody, against GPI-anchorless splice variant of prion protein
|
more |
|
HR-3Y1-2 |
JCRB0743 |
rat |
embryo
|
3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
|
more |
|
hs-103-3 |
JCRB1096 |
hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
more |
|
hs-164-2 |
JCRB1097 |
hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
more |
|
hs-171-1 |
JCRB1098 |
hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
more |
|
hs-172-3 |
JCRB1099 |
hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
more |
|
hs-211 |
JCRB1100 |
hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
more |
|
HS-22 |
JCRB1215 |
mouse |
bone marrow
|
mesenchymal stem cell line
|
more |
|
hs-222-3 |
JCRB1101 |
hamster, Chinese |
lung
|
heat-sensitive anchorage-independent growth mutant of CHL
|
more |
|
Hs68 |
IFO50350 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
HSC-1 |
JCRB1015 |
human |
skin
|
squamous carcinoma
|
more |
|
HSC-2 |
JCRB0622 |
human |
oral
|
squamous carcinoma, mouth
|
more |
|
HSC-3 |
JCRB0623 |
human |
oral
|
squamous carcinoma, tongue
|
more |
|
HSC-4 |
JCRB0624 |
human |
oral
|
squamous carcinoma, tongue
|
more |
|
HSC-5 |
JCRB1016 |
human |
skin
|
squamous carcinoma
|
more |
|
HSC-F |
JCRB1164 |
monkey, Cynomolgus |
hemo-lymphocytic
|
HSV-immortalized T-cell line, susceptible to SIV
|
more |
|
HSGc-C5 |
JCRB1070 |
human |
HeLa-contaminant
|
originally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation.
|
more |
|
HSP-239 |
JCRB1165 |
chimpanzee |
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
|
more |
|
HSP-250 |
JCRB1177 |
chimpanzee |
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
|
more |
|
HSR-5 |
JCRB1211 |
monkey, rhesus |
hemo-lymphocytic
|
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
|
more |
|
HS-Sultan |
JCRB9062 |
human |
hemo-lymphocytic
|
established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
|
more |
|
HT100 |
JCRB0221 |
hamster, Syrian |
lung
|
lung, new born
|
more |
|
HT-1080 |
IFO50354 |
human |
sarcoma
|
fibrosarcoma, acetabulum
|
more |
|
HT-1080 |
JCRB9113 |
human |
sarcoma
|
fibrosarcoma, acetabulum
|
more |
|
HTC/C3 |
JCRB0164 |
human |
thyroid
|
thyroid carcinoma
|
more |
|
HuCCT1 |
JCRB0425 |
human |
liver, gallbladder
|
bile duct carcinoma
|
more |
| *8) |
huH-1 |
JCRB0199 |
human |
liver, gallbladder
|
hepatoma, HBs antigen-positive, HBc(-), HBe(-).
|
more |
|
HuH28 |
JCRB0426 |
human |
liver, gallbladder
|
bile duct carcinoma
|
more |
|
HUH-6 Clone 5 |
JCRB0401 |
human |
liver, gallbladder
|
hepatoblastoma, well differentiated
|
more |
|
HuH-7 |
JCRB0403 |
human |
liver, gallbladder
|
hepatoma, differentiated
|
more |
| *1) |
Human Mucosal cells |
JCRB9116 |
human |
colon
|
colon
|
more |
|
HuO-3N1 |
JCRB0413 |
human |
sarcoma
|
osteosarcoma, ilium
|
more |
|
HuO9 |
JCRB0427 |
human |
sarcoma
|
osteosarcoma
|
more |
|
HuO9N2 |
JCRB0428 |
human |
sarcoma
|
osteosarcoma
|
more |
|
HUV-EC-C |
IFO50271 |
human |
vascular system
|
normal endothelial cell, umbilical cord
|
more |
|
I |
Page Top |
|
|
|
|
|
I-10 |
JCRB9097 |
mouse |
testis
|
Leydig cell testicular tumor (BALB/cJ mouse)
|
more |
|
I51T |
JCRB1225 |
mouse |
skin
|
deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
|
more |
|
IAR-20 |
JCRB0610 |
rat |
liver
|
non-transformed live cell line, (BD-IV rat)
|
more |
|
IHH-4 |
JCRB1079 |
human |
thyroid
|
thyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.)
|
more |
|
IM-9 |
IFO50025 |
human |
hemo-lymphocytic
|
myeloma, multiple, B lymphoblastic
|
more |
|
IM-9 |
JCRB0024 |
human |
hemo-lymphocytic
|
myeloma, multiple, B lymphoblastic
|
more |
|
IM95 |
JCRB1075.0 |
human |
stomach
|
adenocarcinoma, moderately differentiated
|
more |
|
IM95m |
JCRB1075.1 |
human |
stomach
|
adenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF
|
more |
|
IMR-32 |
IFO50283 |
human |
neural
|
neuroblastoma
|
more |
|
IMR-32 |
JCRB9050 |
human |
neural
|
neuroblastoma
|
more |
| *4) |
IMR-90 |
JCRB0516 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
|
IMR-90 |
JCRB9054 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
|
IMR-90-40 |
JCRB0519 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
|
more |
| *3) |
IMR-90-50 |
JCRB0520 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 50
|
more |
|
Indian Muntjac |
JCRB9100 |
Indian Muntjak |
skin
|
used for chromosomal study
|
more |
|
IT-26R21 |
IFO50078 |
rat |
thymus
|
T cell differentiation factor producing, (Wistar rat)
|
more |
|
IT-45R1 |
IFO50076 |
rat |
thymus
|
T cell differentiation factor producing, (Wistar rat)
|
more |
|
IT-45R91 |
IFO50077 |
rat |
thymus
|
thymic fibroblast, (Wistar rat)
|
more |
|
IT-79MTNC3 |
IFO50248 |
mouse |
thymus
|
thymic nurse cell, (BALB/c mouse)
|
more |
|
ITO-II |
JCRB0613 |
human |
testis
|
testicular tumor, (embryonal tumor)
|
more |
|
J |
Page Top |
|
|
|
|
|
J-111 |
IFO50005 |
human |
HeLa-contaminant
|
originally established from acute monocytic leukemia, HeLa-contaminated
|
more |
|
J-111 |
JCRB0073 |
human |
HeLa-contaminant
|
originally established from acute monocytic leukemia, HeLa-contaminated
|
more |
|
J774.1 |
JCRB0018 |
mouse |
hemo-lymphocytic
|
monocyte-macrophage, IL-1-producing, (BALB/c mouse)
|
more |
|
J774A.1 |
JCRB9108 |
mouse |
hemo-lymphocytic
|
monocyte-macrophage, (BALB/c mouse)
|
more |
| *6) |
JHH-1 |
JCRB1062 |
human |
liver, gallbladder
|
hepatoma
|
more |
| *6) |
JHH-2 |
JCRB1028 |
human |
liver, gallbladder
|
hepatoma
|
more |
| *6) |
JHH-4 |
JCRB0435 |
human |
liver, gallbladder
|
hepatoma
|
more |
| *6) |
JHH-5 |
JCRB1029 |
human |
liver, gallbladder
|
hepatoma
|
more |
| *6) |
JHH-6 |
JCRB1030 |
human |
liver, gallbladder
|
hepatoma
|
more |
| *6) |
JHH-7 |
JCRB1031 |
human |
liver, gallbladder
|
hepatoma, HBV-integration
|
more |
|
JKT-beta-del |
JCRB0147 |
human |
hemo-lymphocytic
|
leukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex
|
more |
|
JTC-11 |
JCRB0424 |
mouse |
ascites
|
Ehrlich ascites
|
more |
|
JTC-16 P3 |
JCRB0714 |
rat |
liver
|
ascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat)
|
more |
|
JTC19 |
JCRB0608 |
rat |
lung
|
lung, (JAR-1 rat)
|
more |
|
K |
Page Top |
|
|
|
|
|
K562 |
JCRB0019 |
human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, differentiation-inducible
|
more |
|
K562/ADM |
JCRB1002 |
human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, adriamycin resistant derivative of K562
|
more |
|
KAI3 |
IFO50518 |
human |
hemo-lymphocytic
|
EBV-infected NK-like cell line, IL-2 dependent
|
more |
|
KALS-1 |
IFO50434 |
human |
neural
|
glioma, GFAP, vimentin and CD13-positive
|
more |
|
Kasumi-1 |
JCRB1003 |
human |
hemo-lymphocytic
|
leukemia, acute myeloid
|
more |
|
Kasumi-3 |
JCRB1004 |
human |
hemo-lymphocytic
|
leukemia, acute myeloperoxidase-negative
|
more |
|
Kasumi-6 |
JCRB1024 |
human |
hemo-lymphocytic
|
leukemia, acute myeloid
|
more |
|
KATOIII |
JCRB0611 |
human |
stomach
|
signet ring cell carcinoma
|
more |
|
KB |
JCRB9027 |
human |
HeLa-contaminant
|
originally established from oral epidermoid carcinoma, HeLa-contaminated
|
more |
|
KCL-22 |
JCRB1317 |
human |
hemo-lymphocytic
|
leukemia, chronic myelocytic, Ph1-positive
|
more |
|
KD |
JCRB9103 |
human |
oral
|
fibroblast, lip
|
more |
|
KG-1 |
JCRB0065 |
human |
hemo-lymphocytic
|
leukemia, acute myeloblastic
|
more |
|
KG-1 |
JCRB9051 |
human |
hemo-lymphocytic
|
leukemia, acute myelogenous
|
more |
|
KG-1-C |
JCRB0236 |
human |
neural
|
mixed glioma, GFAP-negative, S-100-positive
|
more |
|
KHM-10B |
JCRB0165 |
human |
hemo-lymphocytic
|
lymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression
|
more |
|
KHM-1B |
JCRB0133 |
human |
hemo-lymphocytic
|
myeloma, multiple, with hyperamylasemia.
|
more |
|
KHM-3S |
JCRB0138 |
human |
lung (cancer)
|
small cell carcinoma, HTLV-1gene integration
|
more |
|
KHM-5M |
JCRB0148 |
human |
thyroid
|
thyroid carcinoma, undifferentiated, IL-8 producing
|
more |
|
KHYG-1 |
JCRB0156 |
human |
hemo-lymphocytic
|
leukemia, NK cell-like, IL-2 dependent
|
more |
|
Ki-JK |
JCRB1065 |
human |
hemo-lymphocytic
|
lymphoma, anaplastic giant cell, Ki-1(CD30)-positive
|
more |
|
KINGS-1 |
IFO50435 |
human |
neural
|
astrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive
|
more |
|
KMBC-2 |
JCRB1148 |
human |
bladder
|
urinary bladder carcinoma
|
more |
|
KMH-2 |
JCRB1066 |
human |
thyroid
|
thyroid anaplastic carcinoma
|
more |
|
KML-1 |
JCRB1347 |
human |
hemo-lymphocytic
|
lymphoma, non-Hodgkins
|
more |
|
KMLS-1 |
JCRB0200 |
human |
sarcoma
|
liposarcoma
|
more |
|
KMM-1 |
JCRB1180 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMPC-3 |
JCRB1150 |
human |
kidney
|
cell line derived from renal pelvis
|
more |
|
KMRC-1 |
JCRB1010 |
human |
kidney
|
renal clear cell carcinoma
|
more |
|
KMRC-2 |
JCRB1011 |
human |
kidney
|
renal clear cell carcinoma
|
more |
|
KMRC-20 |
JCRB1071 |
human |
kidney
|
renal cancer
|
more |
|
KMRC-3 |
JCRB1012 |
human |
kidney
|
renal clear cell carcinoma (growth is very slow)
|
more |
| *4) |
KMRC-5 |
JCRB1007 |
human |
kidney
|
renal clear cell carcinoma
|
more |
|
KMRM-M1 |
JCRB1014 |
human |
kidney
|
renal carcinoma
|
more |
|
KMS-11 |
JCRB1179 |
human |
hemo-lymphocytic
|
myeloma, multiple, IgG kappa-secreting, EBNA(-)
|
more |
|
KMS-12-BM |
JCRB0429 |
human |
hemo-lymphocytic
|
myeloma, late stage of B-cell differentiation
|
more |
|
KMS-12-PE |
JCRB0430 |
human |
hemo-lymphocytic
|
myeloma, late stage of B-cell differentiation
|
more |
|
KMS-20 |
JCRB1196 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMS-21BM |
JCRB1185 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMS-26 |
JCRB1187 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMS-27 |
JCRB1188 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMS-28BM |
JCRB1192 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMS-28PE |
JCRB1191 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMS-34 |
JCRB1195 |
human |
hemo-lymphocytic
|
myeloma
|
more |
|
KMS-6 |
JCRB0432 |
human |
embryo
|
fibroblast, normal diploid
|
more |
|
KMST-6 |
JCRB0433 |
human |
embryo
|
fibroblast, immortalized by 60Co irradiation, derivative of KMS-6
|
more |
| *1) |
KMST-6/T |
JCRB0434 |
human |
embryo
|
fibroblast, immortalized after extensive passages, derivative of KMS-6
|
more |
|
KNS-42 |
IFO50356 |
human |
neural
|
glioma, GFAP-positive, S-100 and NSE-negative
|
more |
|
KNS-60 |
IFO50357 |
human |
neural
|
glioma, GFAP, S-100 and NSE-negative
|
more |
|
KNS-62 |
IFO50358 |
human |
lung (cancer)
|
bronchial squamous carcinoma, metastasis to brain
|
more |
|
KNS-81 |
IFO50359 |
human |
neural
|
glioma, GFAP and S-100-positive, NSE-negative
|
more |
|
KNS-81-FD |
IFO50444 |
human |
neural
|
glioma, derivative of KNS-81 adapted to serum-free medium
|
more |
| *1) |
KNS-89 |
IFO50360 |
human |
neural
|
gliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.)
|
more |
| *5) |
KO51 |
JCRB0122 |
human |
hemo-lymphocytic
|
leukemia, acute myeloblastic, contamination of K562 has been suspected.
|
more |
|
KO52 |
JCRB0123 |
human |
hemo-lymphocytic
|
leukemia, acute myeloblastic
|
more |
|
KON |
JCRB0194 |
human |
oral
|
squamous carcinoma, mouth, ras P21 expression
|
more |
|
KOSC-2 cl3-43 |
JCRB0126.1 |
human |
oral
|
squamous carcinoma, stage III, oral floor
|
more |
| *5) |
KOSC-3 |
JCRB0127 |
human |
oral
|
squamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected.
|
more |
| *5) |
KP-1N |
JCRB0177.0 |
human |
pancreas
|
pancreatic cancer, adenocarcinoma (distribution is suspended)
|
more |
| *5) |
KP-1NL |
JCRB0177.1 |
human |
pancreas
|
pancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended)
|
more |
|
KP-2 |
JCRB0181 |
human |
pancreas
|
pancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma
|
more |
|
KP-3 |
JCRB0178.0 |
human |
pancreas
|
pancreatic cancer, adenosquamous carcinoma
|
more |
|
KP-3L |
JCRB0178.1 |
human |
pancreas
|
pancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice
|
more |
|
KP-4 |
JCRB0182 |
human |
pancreas
|
pacnreatic ductal cell carcinoma, secreting PTHrP
|
more |
|
KP-N-RT-BM-1 |
IFO50432 |
human |
neural
|
neuroblastoma, from bone marrow, neuronal and Schwannian differentiation
|
more |
|
KP-N-SI9s |
IFO50433 |
human |
neural
|
neuroblastoma, from lymph node, smooth muscle marker-expressing
|
more |
|
KP-N-YN |
IFO50431 |
human |
neural
|
neuroblastoma, from lymph node, smooth muscle marker-expressing
|
more |
|
KS-1 |
IFO50436 |
human |
neural
|
glioblastoma
|
more |
|
KT-5 |
IFO50161 |
mouse |
neural
|
astrocyte line, GFAP-positive, (C3H/He mouse)
|
more |
|
KU812 |
IFO50363 |
human |
hemo-lymphocytic
|
leukemia, chronic myeloid
|
more |
|
KU812 |
JCRB0104 |
human |
hemo-lymphocytic
|
leukemia, chronic myeloid
|
more |
|
KU812E |
JCRB0104.1 |
human |
hemo-lymphocytic
|
leukemia, chronic myeloid
|
more |
|
KU812F |
JCRB0104.2 |
human |
hemo-lymphocytic
|
leukemia, chronic myeloid
|
more |
|
KUM10 |
JCRB1176 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUM3 |
JCRB1134 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUM4 |
JCRB1135 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUM5 |
JCRB1178 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUM6 |
JCRB1202 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUM7 |
JCRB1204 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUM9 |
JCRB1139 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KURAMOCHI |
JCRB0098 |
human |
ovary
|
undifferentiated carcinoma, ascites
|
more |
|
KUSA-A1 |
JCRB1119 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUSA-H1 |
JCRB1129 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KUSA-O |
JCRB1132 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
KY821 |
JCRB0105 |
human |
hemo-lymphocytic
|
leukemia, acute myeloid
|
more |
|
KY821A3 |
JCRB0105.1 |
human |
hemo-lymphocytic
|
leukemia, acute myeloid, subclone of KY821
|
more |
|
KYM-1 |
JCRB0627 |
human |
sarcoma
|
rhabdomyosarcoma, neck
|
more |
| *6) |
KYSE110 |
JCRB1064 |
human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE140 |
JCRB1063 |
human |
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE150 |
JCRB1095 |
human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE170 |
JCRB1082 |
human |
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE180 |
JCRB1083 |
human |
esophagus
|
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE220 |
JCRB1086 |
human |
esophagus
|
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE270 |
JCRB1087 |
human |
esophagus
|
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE30 |
JCRB0188 |
human |
esophagus
|
squamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE50 |
JCRB0189 |
human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
| *6) |
KYSE70 |
JCRB0190 |
human |
esophagus
|
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
|
more |
|
L |
Page Top |
|
|
|
|
|
L alpha |
JCRB0125 |
mouse |
skin
|
L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
|
more |
|
L cl 1D |
JCRB0722 |
mouse |
skin
|
fibroblast, thymidine kinase-deficient, (C3H mouse)
|
more |
|
L.P3 |
JCRB0648 |
mouse |
skin
|
serum-free adapted L929 cell line
|
more |
|
L.P3(S) |
JCRB0605 |
mouse |
skin
|
L cell derived, can grow in a serum-free medium, (C3H mouse)
|
more |
|
L1210 |
JCRB9026 |
mouse |
hemo-lymphocytic
|
leukemia, lymphocytic, (DBA/2 mouse)
|
more |
|
L-2 |
JCRB9053 |
rat |
lung
|
adult lung
|
more |
|
L2C |
IFO50210 |
guinea pig |
hemo-lymphocytic
|
leukemic cell, maintainable only by transplantation
|
more |
|
L5178Y |
JCRB0709 |
mouse |
hemo-lymphocytic
|
lymphoma, methylcholanthrene induced, (DBA/2 mouse)
|
more |
|
L5178Y TK+/-3.7.2c |
JCRB0709.1 |
mouse |
hemo-lymphocytic
|
L5178Y derivative, thymidine kinase +/- heterozygotic line
|
more |
|
L5178Y ts2 |
JCRB0723 |
mouse |
hemo-lymphocytic
|
L5178Y derivative, abnormal cell division at non-permissive temperature
|
more |
|
L5178Y ts39 |
JCRB0724 |
mouse |
hemo-lymphocytic
|
L5178Y derivative, micronucleation at non-permissive temperature
|
more |
|
L6 |
IFO50364 |
rat |
muscular system
|
skeletal muscle myoblast
|
more |
|
L6 |
JCRB9081 |
rat |
muscular system
|
skeletal muscle myoblast
|
more |
|
L6TG |
JCRB0209 |
rat |
muscular system
|
skeletal muscle myoblast, 6-thioguanine-resistant
|
more |
|
L6TG Cap |
JCRB0210 |
rat |
muscular system
|
skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant
|
more |
|
LC-1 sq |
JCRB0258 |
human |
lung (cancer)
|
squamous cell carcinoma
|
more |
|
LC4-1 |
JCRB0114 |
human |
hemo-lymphocytic
|
leukemia, acute non T lymphoblastic
|
more |
|
LC540 |
JCRB9064 |
rat |
testis
|
Leydig cell testicular tumor
|
more |
|
LI90 |
JCRB0160 |
human |
liver, gallbladder
|
liver Ito cells (limited life span)
|
more |
|
LK-2 |
JCRB0829 |
human |
lung (cancer)
|
squamous cell carcinoma
|
more |
|
LLC-PK1 |
JCRB0060 |
pig |
kidney
|
susceptible to rubella, vaccinia and herpes viruses
|
more |
|
LLC-RK1 |
JCRB9034 |
rabbit |
kidney
|
an aneuploid cell line, (New Zealand white rabbit)
|
more |
|
LMH |
JCRB0237 |
chicken |
liver
|
hepatocelluler carcinoma, diethylnitrosamine induced
|
more |
|
LoVo |
IFO50067 |
human |
colon
|
adenocarcinoma, carcinoembryonic antigen-producing
|
more |
|
LoVo |
JCRB9083 |
human |
colon
|
adenocarcinoma, carcinoembryonic antigen-producing
|
more |
|
Lu-134-A-H |
JCRB0235 |
human |
lung (cancer)
|
small cell carcinoma, classic type
|
more |
|
Lu-134-B |
JCRB0169 |
human |
lung (cancer)
|
small cell carcinoma
|
more |
|
Lu-135 |
JCRB0170 |
human |
lung (cancer)
|
small cell carcinoma, variant type
|
more |
|
LU65 |
JCRB0079 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LU65A |
JCRB0054 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LU65B |
JCRB0055 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LU65C |
JCRB0056 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LU99 |
JCRB0080 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LU99A |
JCRB0044 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LU99B |
JCRB0057 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LU99C |
JCRB0058 |
human |
lung (cancer)
|
giant cell carcinoma
|
more |
|
LYM-1.P3 |
JCRB0144.1 |
rat |
lymph node
|
sticky cell from lymph node, serum-free, (JAR-2 rat)
|
more |
|
LYM-1.P3B |
JCRB0144.1B |
rat |
lymph node
|
sticky cell from lymph node, subclone of LYM-1.P3
|
more |
|
LYM-1.P3D |
JCRB0144.1D |
rat |
lymph node
|
sticky cell from lymph node, subclone of LYM-1.P3
|
more |
|
M |
Page Top |
|
|
|
|
|
M |
JCRB0152.1 |
rat |
liver
|
DAB transformed liver cell line, (JAR rat)
|
more |
|
M.dunni(Clone III8C) |
JCRB9124 |
pygmy mouse |
tail
|
normal, support the growth of all 4 classes of MuLV
|
more |
|
M.P3 |
JCRB0152.2 |
rat |
liver
|
DAB transformed liver cell line, protein and lipid-free culture, (JAR rat)
|
more |
|
M.P3 |
JCRB0152.3 |
rat |
liver
|
DAB transformed liver cell line, protein and lipid-free culture, deposited directly by original developer (JAR rat)
|
more |
|
M1 |
IFO50006 |
mouse |
hemo-lymphocytic
|
spontaneous myeloid leukemia, differentiation into macrophage/granulocyte, (SL mouse)
|
more |
|
M1-T22 |
JCRB0110 |
mouse |
hemo-lymphocytic
|
leukemia, spontaneous myeloblastic, differentiation-inducible, (SL mouse)
|
more |
|
m5S |
JCRB1322 |
mouse |
skin
|
3T3-like near-diploid, derived from embryonic skin (ICR/Jcl mouse)
|
more |
|
MA-89 |
IFO50293 |
mouse |
neural
|
normal mixed glial culture, (C3H/He mouse)
|
more |
| *5) |
Marcus |
IFO50290 |
human |
neural
|
astrocytoma, GFAP-negative, (distribution is suspended)
|
more |
|
MB86 |
JCRB0090 |
mouse |
antibody-producing hybridoma
|
anti-Igh6-4 antibody-producing, IgM, (BALB/c mouse)
|
more |
|
MBT2 |
IFO50041 |
mouse |
bladder
|
bladder carcinoma
|
more |
|
MCAS |
JCRB0240 |
human |
ovary
|
mucinous cystadenocarcinoma
|
more |
|
MCA-TCL16 |
JCRB0712 |
mouse |
embryo
|
C3H10T1/2 cl-8 derivative, methylcholanthrene-transformed, (C3H mouse)
|
more |
|
MCF-7 |
JCRB0134 |
human |
mammary
|
mammary tumor
|
more |
|
MDBK (NBL-1) |
IFO50014 |
bovine |
kidney
|
established from normal kidney
|
more |
|
MDBK (NBL-1) |
JCRB9028 |
bovine |
kidney
|
established from normal kidney
|
more |
|
MDBK.P3 |
JCRB0716 |
bovine |
kidney
|
normal kidney, MDBK derivative, no serum required
|
more |
|
MDCK (NBL-2) |
IFO50071 |
dog |
kidney
|
established from normal kidney, susceptible for many viral species
|
more |
|
MDCK (NBL-2) |
JCRB9029 |
dog |
kidney
|
established from normal kidney, susceptible for many viral species
|
more |
|
MDCK.P3 |
JCRB0717 |
dog |
kidney
|
normal kidney, MDCK derivative, no serum required
|
more |
|
MDM2-RNB |
IFO50490 |
rat |
neural
|
human MDM2 protein-expressing astrocyte cell line, (Wistar rat)
|
more |
|
ME-180 |
JCRB0810 |
human |
uterine cervix
|
cervical carcinoama
|
more |
|
MEB 5 |
JCRB0145 |
mouse |
neural
|
CNS stem cell line, HPV type 16 E7-immortalized, (C3H/He mouse)
|
more |
|
MEB5 |
IFO50472 |
mouse |
neural
|
CNS stem cell line, HPV type 16 E7-immortalized, (C3H/He mouse)
|
more |
|
MEG-01 |
IFO50151 |
human |
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic
|
more |
|
MEG-01s |
IFO50473 |
human |
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic, MEG-01-derivative
|
more |
|
MEG-01SSF |
IFO50294 |
human |
hemo-lymphocytic
|
leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium
|
more |
|
MEG-A2 |
IFO50478 |
human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, megakaryoblastic cell line
|
more |
|
Mewo |
JCRB0066 |
human |
melanoma
|
malignant melanoma
|
more |
|
MG5 |
IFO50520 |
mouse |
neural
|
microglial cell line, p53-deficient. Requires A1 conditioned medium for culture.
|
more |
|
MG-63 |
IFO50108 |
human |
sarcoma
|
osteosarcoma
|
more |
|
MIA PaCa-2 |
JCRB0070 |
human |
pancreas
|
pancreatic cancer
|
more |
|
MiTen |
JCRB0072 |
human |
skin
|
Lesh-Nyhan syndrome, skin fibroblast
|
more |
|
Miz-1 |
IFO50300 |
human |
embryo
|
limb interstitial tissue, normal diploid fibroblast
|
more |
|
MK.P3 |
JCRB0607.1 |
monkey, Cynomolgus |
kidney
|
MK (JTC-12) cells adapted to serum-free medium
|
more |
|
MK.P3(F) |
JCRB0607 |
monkey, Cynomolgus |
kidney
|
other name is JTC-12.P3(F)
|
more |
|
MKN1 |
JCRB0252 |
human |
stomach
|
adenosquamous carcinoma
|
more |
|
MKN28 |
JCRB0253 |
human |
stomach
|
tubular adenocarcinoma, moderately differentiated, contamination with MKN74 has been suspected
|
more |
|
MKN45 |
JCRB0254 |
human |
stomach
|
adenocarcinoma, poorly differentiated
|
more |
|
MKN7 |
JCRB1025 |
human |
stomach
|
tubular adenocarcinoma, well differentiated
|
more |
|
MKN74 |
JCRB0255 |
human |
stomach
|
tubular adenocarcinoma, moderately differentiated
|
more |
|
MKPL-1 |
JCRB1325 |
human |
hemo-lymphocytic
|
leukemia, acute megakaryoblastic
|
more |
|
MLMA |
JCRB0146 |
human |
hemo-lymphocytic
|
lymphoma, malignant, hairy B-cell line
|
more |
|
Mm1 |
IFO50008 |
mouse |
hemo-lymphocytic
|
spontaneous myeloid leukemia, M-1-derivative, macrophage-like phenotype, (SL mouse)
|
more |
| *1) |
Mm2T |
JCRB0609 |
Indian Muntjak |
thymus
|
thymus
|
more |
|
Mm2T.P3 |
JCRB0609.1 |
Indian Muntjak |
thymus
|
thymus, serum-free adapted Mm2T
|
more |
|
Mm2T12.P3 |
JCRB0650.1 |
Indian Muntjak |
thymus
|
subline of Mm2T, serum-free
|
more |
|
MMT 060562 |
JCRB9077 |
mouse |
mammary
|
spontaneous mammary tumor
|
more |
|
MOLT-3 |
JCRB9048 |
human |
hemo-lymphocytic
|
leukemia, acute lymphoblastic
|
more |
|
MOLT-4 |
IFO50362 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
MOLT-4 |
JCRB9031 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
MOLT-4F |
JCRB0021 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
MOR35.4.12 |
JCRB1342.02 |
mouse |
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
|
more |
|
MOR8.2.1 |
JCRB1342.01 |
mouse |
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
|
more |
|
MOR83.3.10 |
JCRB1342.05 |
mouse |
antibody-producing hybridoma
|
anti-morphine antibody, IgG1(k)
|
more |
|
MPC 11 OUAr |
JCRB9106 |
mouse |
hemo-lymphocytic
|
myeloma, ourbain resistant
|
more |
|
MRC-5 |
IFO50073 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
|
MRC-5 |
JCRB9008 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
|
MRC-5-30 |
JCRB0521 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30
|
more |
| *3) |
MRC-5-40 |
JCRB0522 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
|
more |
| *3) |
MRC-5-50 |
JCRB0523 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 50
|
more |
|
MRC-9 |
IFO50072 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
|
MRC-9 |
JCRB9060 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
| *4) |
MRC-9-30 |
JCRB0524 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30, (not available.)
|
more |
|
MRK-nu-1 |
JCRB0628 |
human |
mammary
|
mammary carcinoma
|
more |
|
MS-1-L |
JCRB1081 |
human |
lung (cancer)
|
small cell carcinoma, PTHrP producing
|
more |
|
MS-653-A |
JCRB1001.1 |
rat |
sarcoma
|
fibrosarcoma, methylcholantheren-induced, highly tumorigenic, (Donryu rat)
|
more |
|
MS-653-G |
JCRB1001.2 |
rat |
sarcoma
|
fibrosarcoma, methylcholantheren-induced, less tumorigenic, (Donryu rat)
|
more |
|
MSK |
JCRB0259 |
rat |
sarcoma
|
osteosarcoma, 32P-induced, (F344 rat)
|
more |
|
MSS31 |
IFO50375 |
mouse |
spleen
|
spleen stromal cell line, (C57BL/6 mouse)
|
more |
|
MSS62 |
IFO50376 |
mouse |
spleen
|
spleen stromal cell line, (C57BL/6 mouse)
|
more |
| *2) |
MT-1 |
JCRB1209 |
human |
hemo-lymphocytic
|
Leukemia, adult T cell, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
| *2) |
MT-2 |
JCRB1210 |
human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
| *2) |
MT-3 |
JCRB1217 |
human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
| *2) |
MT-4 |
JCRB0135 |
human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I antigen-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
| *2) |
MT-4 |
JCRB1216 |
human |
hemo-lymphocytic
|
HTLV-I-transformed leukocytes, HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
|
MT-45-5-3 |
JCRB1304 |
mouse |
antibody-producing hybridoma
|
anti-metallothionein antibody-producing, IgG1(k)
|
more |
|
MTA |
IFO50513 |
human |
hemo-lymphocytic
|
leukemia, NK-like T cell line
|
more |
|
Mv 1 Lu |
JCRB9128 |
mink |
lung
|
useful for focus forming assays of murine and feline sarcoma virus
|
more |
|
MY |
JCRB0158.0 |
human |
hemo-lymphocytic
|
leukemia, acute biphenotypic, bone marrow mononuclear cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL
|
more |
|
MY-M12 |
JCRB0158.1 |
human |
hemo-lymphocytic
|
leukemia, acute biphenotypic, subclone of the MY cells
|
more |
|
MY-M13 |
JCRB0158.2 |
human |
hemo-lymphocytic
|
leukemia, acute biphenotypic, subclone of the MY cells
|
more |
|
N |
Page Top |
|
|
|
|
|
N18-RE-105 |
IFO50221 |
mouse x rat |
neural
|
N18TG2 x Fischer rat embryonic neural retina
|
more |
|
NAGL-1 |
IFO50479 |
human |
hemo-lymphocytic
|
leukemia, acute pre B lymphoblastic, B cell line
|
more |
|
NALL-1 |
JCRB1332 |
human |
hemo-lymphocytic
|
leukemia, acute lymphocytic
|
more |
|
Namalwa |
IFO50040 |
human |
hemo-lymphocytic
|
lymphoma, Burkitt's
|
more |
|
NB(TU)1-10 |
JCRB0154 |
human |
neural
|
neuroblastoma, stage III
|
more |
|
NB-1 |
IFO50295 |
human |
neural
|
neuroblastoma
|
more |
|
NB-1 |
JCRB0621 |
human |
neural
|
neuroblastoma
|
more |
|
NC02 |
IFO50525 |
human |
hemo-lymphocytic
|
leukemia, chronic myelogenous, Ph1 chromosome-positive
|
more |
|
NC-37 |
IFO50039 |
human |
hemo-lymphocytic
|
lymphoblast, Contamination of Raji cells has been suspected.
|
more |
|
NCC16-P11 |
JCRB0174.0 |
human |
uterine cervix
|
normal epithelial cells immortalized with HPV16, EGF-independent
|
more |
|
NCC-IT-A3 |
JCRB1005 |
human |
teratocarcinoma
|
teratocarcinoma from anterior mediastinum, HST-1 oncogene-expressing
|
more |
|
NCC-OvC-K119 |
JCRB1308 |
human |
ovary
|
ovarian carcinoma (growth is extremely slow)
|
more |
|
NCC-RbC-39 |
JCRB1305 |
human |
neural
|
retinoblastoma, unilateral (growth is very slow)
|
more |
|
NCC-RbC-51 |
JCRB1182 |
human |
neural
|
retinoblastoma, bilateral
|
more |
|
NCC-RbC-54 |
JCRB1183 |
human |
neural
|
retinoblastoma, bilateral
|
more |
|
NCC-RbC-56 |
JCRB1212 |
human |
neural
|
retinoblastoma, bilateral
|
more |
|
NCC-RbC-57 |
JCRB1190 |
human |
neural
|
retinoblastoma, unilateral (growth is very slow)
|
more |
|
NCC-RbC-67 |
JCRB1214 |
human |
neural
|
retinoblastoma, unilateral
|
more |
|
NCC-RbC-92 |
JCRB1221 |
human |
neural
|
retinoblastoma, unilateral (growth is very slow)
|
more |
|
NCC-RbC-T1 |
JCRB1223 |
human |
neural
|
retinoblastoma, bilateral (growth is very slow)
|
more |
|
NCC-StC-K140 |
JCRB1228 |
human |
stomach
|
adenocarcinoma
|
more |
|
NCE 16IIA |
JCRB1090 |
human |
uterine cervix
|
normal keratinocyte immortalized with HPV16
|
more |
|
NCE16 |
JCRB0140 |
human |
uterine cervix
|
normal keratinocyte immortalized with HPV16
|
more |
|
NCR-G1 |
JCRB1166 |
human |
testis
|
testicular germ cell tumor, yolk sac tumor-like characteristics
|
more |
|
NCR-G2 |
JCRB1167 |
human |
testis
|
testicular germ cell tumor, embrional carcinoma
|
more |
|
NCR-G3 |
JCRB1168 |
human |
testis
|
testicular germ cell tumor, embryonal carcinoma
|
more |
|
NCR-G4 |
JCRB1175 |
human |
testis
|
testicular germ cell tumor, embrional carcinoma
|
more |
|
NCTC clone 1469 |
IFO50080 |
mouse |
liver
|
normal liver-derived, (C3H/An mouse)
|
more |
|
NCTC Clone 1469 |
JCRB9075 |
mouse |
liver
|
normal liver-derived, (C3H/An mouse)
|
more |
|
NCTC clone 929 |
IFO50409 |
mouse |
skin
|
fibroblast, subclone of strain L, (C3H/An mouse)
|
more |
|
NCTC Clone 929 |
JCRB9003 |
mouse |
skin
|
fibroblast, subclone of strain L, (C3H/An mouse)
|
more |
|
NEC14 |
JCRB0162 |
human |
testis
|
testicular germ cell tumor
|
more |
|
NEC8 |
JCRB0250 |
human |
testis
|
testicular germ cell tumor
|
more |
|
Neuro-2a |
IFO50081 |
mouse |
neural
|
neuroblastoma, (A albino mouse)
|
more |
|
Neuro-2aTG |
IFO50495 |
mouse |
neural
|
neuroblastoma, 6-thioguanine-resistant,HAT-sensitive, (A albino mouse)
|
more |
|
NG-3Y1-T15L |
JCRB0739 |
rat |
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
|
more |
|
NG-3Y1-T308 |
JCRB0740 |
rat |
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
|
more |
|
NG-3Y1-T6R |
JCRB0741 |
rat |
embryo
|
3Y1 derivative, transformed by MNNG, (Fischer rat)
|
more |
|
NH-12 |
JCRB0833 |
human |
neural
|
neuroblastoma, adrenal gland
|
more |
|
NH-6 |
JCRB0832 |
human |
neural
|
neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia
|
more |
|
NIH 3T3 p-7 cl-3 |
IFO50019 |
mouse |
embryo
|
fibroblast, contact inhibited, (NIH Swiss mouse)
|
more |
|
NIH/3T3 clone 5611 |
JCRB0615 |
mouse |
embryo
|
fibroblast, contact inhibited, (NIH Swiss mouse)
|
more |
|
NIL |
IFO50018 |
hamster, Syrian |
embryo
|
transformed from hamster fibroblast
|
more |
|
NIL-SF2 |
IFO50426 |
hamster, Syrian |
embryo
|
NIL subline adapted to serum-free medium
|
more |
|
NJG |
IFO50322 |
human |
uterus
|
gestational uterine choriocarcinoma
|
more |
|
NKM-1 |
IFO50476 |
human |
hemo-lymphocytic
|
leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth
|
more |
|
NKY113 |
IFO50279 |
mouse |
antibody-producing hybridoma
|
MSW113 antibody, recognizing a cancer-associated olygosaccharide
|
more |
|
NM-1 |
JCRB0155 |
bovine |
vascular system
|
aortic normal endothelial cell, (SMA-positive smooth muscle cells are intermingled.)
|
more |
|
NMC-G1 |
IFO50467 |
human |
neural
|
glioma, FGF-9-producing
|
more |
| *8) |
no.10 |
IFO50368 |
human |
neural
|
glioma, anaplastic, GFAP-positive
|
more |
| *8) |
no.11 |
IFO50369 |
human |
neural
|
glioma, anaplastic, GFAP-positive
|
more |
|
NOMO-1 |
IFO50474 |
human |
hemo-lymphocytic
|
leukemia, acute monocytic, promonocytic leukemia cells
|
more |
|
NOMO-1/ADM |
JCRB1069 |
human |
hemo-lymphocytic
|
leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1
|
more |
|
NOMO-1s |
IFO50475 |
human |
hemo-lymphocytic
|
leukemia, acute monocytic, NOMO-1-derivative adapted to serum-free medium
|
more |
| *6) |
NOZ |
JCRB1033 |
human |
liver, gallbladder
|
gallbladder carcinoma, tubular adenocarcinoma, moderately differentiated
|
more |
|
NRG |
JCRB1138 |
mouse |
bone marrow
|
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
|
more |
|
NRK-49F |
IFO50481 |
rat |
kidney
|
fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
|
more |
|
NRK-49F |
JCRB9067 |
rat |
kidney
|
fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
|
more |
|
NRK-52E |
IFO50480 |
rat |
kidney
|
epithelioid clone of NRK (normal rat kidney) cells, (Osbone-Mendel rat)
|
more |
|
NTI-4 |
JCRB0220 |
human |
embryo
|
fibroblast, fetus, half body, bottom
|
more |
|
NTI-5 |
JCRB0222 |
human |
embryo
|
fibroblast, fetus, half a body
|
more |
|
NUGC-2 |
JCRB0821 |
human |
stomach
|
adenocarcinoma, poorly differentiated
|
more |
|
NUGC-3 |
JCRB0822 |
human |
stomach
|
adenocarcinoma, poorly differentiated
|
more |
|
NUGC-4 |
JCRB0834 |
human |
stomach
|
adenocarcinoma, poorly differentiated, signet ring cell carcinoma
|
more |
|
NY |
JCRB0614 |
human |
sarcoma
|
osteosarcoma, femur
|
more |
|
O |
Page Top |
|
|
|
|
|
OCUG-1 |
JCRB0191 |
human |
liver, gallbladder
|
gallbladder carcinoma, malignant
|
more |
|
OCUM-1 |
JCRB0192 |
human |
stomach
|
adenocarcinoma, poorly differentiated, containing signet ring cells
|
more |
|
OHP101.B11.1 |
JCRB1316.2 |
mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
more |
|
OHP138.H8.1 |
JCRB1316.3 |
mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
more |
|
OHP1E9.3.1 |
JCRB1316.4 |
mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
more |
|
OHP57.G6.1 |
JCRB1316.1 |
mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
more |
|
OHP7D7.2.3 |
JCRB1316.6 |
mouse |
antibody-producing hybridoma
|
anti-17alpha-hydroxyprogesterone, IgG(k)
|
more |
|
OKa-C-1 |
JCRB1343 |
human |
lung (cancer)
|
squamous cell carcinoma, poorly differentiated, G-CSF and PTHrP producing
|
more |
|
ONS-76 |
IFO50355 |
human |
neural
|
medulloblastoma
|
more |
|
OSC-19 |
JCRB0198 |
human |
oral
|
squamous carcinoma, tongue, serum-free culture
|
more |
|
OSC-20 |
JCRB0197 |
human |
oral
|
squamous carcinoma, tongue, serum-free culture
|
more |
|
OTT6050 |
JCRB0720 |
mouse |
teratoma
|
teratocarcinoma, (129/Sv mouse)
|
more |
|
OUMS-23 |
JCRB1022 |
human |
colon
|
adenocarcinoma, from familial adenomatous polyposis patient, reduction of APC gene expression
|
more |
|
OUMS-24/P6X |
JCRB1051 |
human |
embryo
|
fibroblast, immortalized by mutant p53 and X-ray, derivative of OUMS-24
|
more |
|
OUMS-27 |
IFO50488 |
human |
sarcoma
|
chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing
|
more |
|
OUMS-36 |
JCRB1006.0 |
human |
embryo
|
normal embryonic fibroblast
|
more |
|
OUMS-36T-1 |
JCRB1006.1 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-1F |
JCRB1006.1F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-2 |
JCRB1006.2 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-2F |
JCRB1006.2F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-3 |
JCRB1006.3 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-3F |
JCRB1006.3F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-4 |
JCRB1006.4 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-4F |
JCRB1006.4F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-5 |
JCRB1006.5 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-5F |
JCRB1006.5F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-6 |
JCRB1006.6 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-6F |
JCRB1006.6F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-7 |
JCRB1006.7 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-7F |
JCRB1006.7F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-8 |
JCRB1006.8 |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUMS-36T-8F |
JCRB1006.8F |
human |
embryo
|
fibroblast, immortalized by hTRT, derivative of OUMS-36
|
more |
|
OUS-11 |
JCRB1034 |
human |
lung
|
normal lung cells, fibroblastic
|
more |
|
OV3121 |
JCRB1026 |
mouse |
ovary
|
ovarian granulosa cell tumor, non-metastatic
|
more |
|
OV3121-ras4 |
JCRB0186 |
mouse |
ovary
|
v-Ha-ras transfected ovarian granulosa cell tumor line OV3121, highly metastatic, ((C57BL/6N x C3H/He) F1 mouse)
|
more |
|
OV3121-ras7 |
JCRB0187 |
mouse |
ovary
|
v-Ha-ras transfected ovarian granulosa cell tumor line OV3121, moderately metastatic, ((C57BL/6N x C3H/He) F1 mouse)
|
more |
|
OVISE |
JCRB1043 |
human |
ovary
|
clear cell adenocarcinoma
|
more |
|
OVKATE |
JCRB1044 |
human |
ovary
|
serous papillary adenocarcinoma (growth is very slow)
|
more |
|
OVMANA |
JCRB1045 |
human |
ovary
|
clear cell adenocarcinoma, (very labile for freezing, and the viability after thawing is very low)
|
more |
|
OVMIU |
JCRB1049 |
human |
ovary
|
adenocarcinoma, exhibits different DNA profile from OVMIU-II (possible misidentification)
|
more |
|
OVMIU-II |
JCRB1050 |
human |
ovary
|
adenocarcinoma, exhibits different DNA profile from OVMIU (possible misidentification)
|
more |
|
OVSAHO |
JCRB1046 |
human |
ovary
|
serous papillary adenocarcinoma
|
more |
|
OVSAYO |
JCRB1047 |
human |
ovary
|
adenocarcinoma, exhibits the same DNA profile as OVMIU (possible misidentification)
|
more |
|
OVTOKO |
JCRB1048 |
human |
ovary
|
clear cell adenocarcinoma
|
more |
| *6) |
OZ |
JCRB1032 |
human |
liver, gallbladder
|
bile duct carcinoma
|
more |
|
P |
Page Top |
|
|
|
|
|
P3.6.2.8.1 |
JCRB9109 |
mouse |
hemo-lymphocytic
|
myeloma, IgG1 secreting, (BALB/c mouse)
|
more |
|
P3/NS1/1-Ag4-1 |
JCRB0009 |
mouse |
hemo-lymphocytic
|
myeloma, 8-azaguanine-resistant, (BALB/c mouse)
|
more |
|
P3/NS1/1-Ag4-1(NS-1) |
JCRB9107 |
mouse |
hemo-lymphocytic
|
myeloma, plasmacytoma, non-secreting, 8-azaguanine resistant
|
more |
|
P30/OHK |
JCRB0094 |
human |
hemo-lymphocytic
|
leukemia, acute non T non B lymphoblastic
|
more |
|
P31/FUJ |
JCRB0091 |
human |
hemo-lymphocytic
|
leukemia, acute monocytic
|
more |
|
P32/ISH |
JCRB0095 |
human |
hemo-lymphocytic
|
lymphoma, Burkitt's
|
more |
|
P388 |
JCRB0017 |
mouse |
hemo-lymphocytic
|
lymphoid neoplasm, methylcholanthrene-induced, (DBA/2 mouse)
|
more |
|
P388D1 |
IFO50036 |
mouse |
hemo-lymphocytic
|
lymphoid neoplasm, derived from P388, (DBA/2 mouse)
|
more |
|
P388-D1 |
JCRB0016 |
mouse |
hemo-lymphocytic
|
lymphoid neoplasm, derived from P388, (DBA/2 mouse)
|
more |
| *5) |
P39/TSU |
JCRB0092 |
human |
hemo-lymphocytic
|
leukemia, acute myeloblastic, contamination with HL60 has been suspected.
|
more |
|
P3U1 |
JCRB0708 |
mouse |
hemo-lymphocytic
|
myeloma
|
more |
|
P3X63Ag8 |
JCRB9105 |
mouse |
hemo-lymphocytic
|
myeloma, plasmacytoma, IgG1(gamma,kappa) secreting, (BALB/c mouse)
|
more |
|
P3X63-Ag8.653 |
JCRB9030 |
mouse |
hemo-lymphocytic
|
myeloma, non-secreting, 8-azaguanine resistant, (BALB/c mouse)
|
more |
|
P3X63Ag8U.1 |
JCRB9085 |
mouse |
hemo-lymphocytic
|
myeloma, plasmacytoma, 8-azaguanine resistant, (BALB/c mouse)
|
more |
|
p53-def-MOSE |
JCRB0151.1 |
mouse |
ovary
|
ovarian surface epithelial cell line from p53(-/-) mouse
|
more |
|
P53LMACO1 |
JCRB0150 |
mouse |
vascular system
|
aortic smooth muscle cell line from p53 knockout mouse
|
more |
|
P-815 |
JCRB0078 |
mouse |
hemo-lymphocytic
|
mastocytoma, (DBA/2 mouse)
|
more |
|
PA-1 |
JCRB9061 |
human |
teratocarcinoma
|
ovarian teratocarcinoma, from ascitic fluid
|
more |
|
PA-1/6TG-r |
JCRB1052 |
human |
teratocarcinoma
|
ovarian teratocarcinoma, HPRT(-) subline of PA-1
|
more |
|
PAI |
JCRB0113 |
mouse |
hemo-lymphocytic
|
myeloma, (BALB/c mouse)
|
more |
|
PALL-2 |
JCRB1345 |
human |
hemo-lymphocytic
|
leukemia, acute lymphoblastic, Ph1 chromosome-positive
|
more |
|
PB-3c |
IFO50267 |
mouse |
hemo-lymphocytic
|
mast cell line
|
more |
|
PC-12 |
IFO50278 |
rat |
neural
|
pheochromocytoma, neuronal differentiation by NGF, grow in suspension
|
more |
|
PC-12 |
JCRB0733 |
rat |
neural
|
pheochromocytoma, , neuronal differentiation by NGF, adhesive variant
|
more |
|
PC-12.P3 |
JCRB0130 |
rat |
neural
|
PC-12 derivative adapted to serum-free culture
|
more |
|
PC-12.P3 |
JCRB0130.1 |
rat |
neural
|
PC-12 derivative adapted to serum-free culture, direct deposition by original developer
|
more |
|
PC12HS |
JCRB0266 |
rat |
neural
|
pheochromocytoma, highly NGF-sensitive clone of PC-12
|
more |
|
PC12HS.P3 |
JCRB0263.1 |
rat |
neural
|
pheochromocytoma, serum-free adapted PC12 HS
|
more |
|
PC12IS |
JCRB0268 |
rat |
neural
|
pheochromocytoma, NGF-insensitive clone of PC-12
|
more |
|
PC12MS |
JCRB0267 |
rat |
neural
|
pheochromocytoma, moderately NGF-sensitive clone of PC-12
|
more |
|
PC-12TG |
IFO50496 |
rat |
neural
|
pheochromocytoma, neuronal differentiation by NGF, 6-thioguanine-resistant,HAT-sensitive
|
more |
|
PC-3 |
JCRB0077 |
human |
lung (cancer)
|
adenocarcinoma, intermediately differentiated
|
more |
|
PC-3 |
JCRB9110 |
human |
prostate gland
|
adenocarcinoma
|
more |
| *1) |
PCC4 |
JCRB0205 |
mouse |
teratoma
|
teratocarcinoma, (129/Sv mouse)
|
more |
|
PCC4 AG |
JCRB0206 |
mouse |
teratoma
|
teratocarcinoma, 8-azaguanine-resistant, (129/Sv mouse)
|
more |
|
PCC4 AG Cap |
JCRB0216 |
mouse |
teratoma
|
teratocarcinoma, 8-azaguanine, chloramphenicol-resistant (129/sv mouse)
|
more |
| *1) |
PCC4 Type I |
JCRB0204 |
mouse x rat |
cybrid
|
PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
|
more |
|
PCC4 TypeIII |
JCRB0203 |
mouse x rat |
cybrid
|
PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
|
more |
|
PEER |
JCRB0830 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphocytic
|
more |
|
PG-4(S+L-) |
JCRB9125 |
cat |
neural
|
brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses
|
more |
|
PHK16-0b |
JCRB0141 |
human |
skin
|
normal keratinocyte immortalized with HPV16.
|
more |
| *2) |
PJS1JTO |
JCRB0320 |
human |
skin
|
Peutz-Jeghers' syndrome, fibroblasts
|
more |
| *2) |
PJS5JTO |
JCRB0321 |
human |
skin
|
Peutz-Jeghers' syndrome, fibroblasts
|
more |
|
PK(15) |
JCRB9040 |
pig |
kidney
|
kidney
|
more |
|
PKF |
IFO50422 |
pig |
kidney
|
susceptible to Vaccinia virus
|
more |
|
PKR |
IFO50423 |
pig |
kidney
|
susceptible to Vaccinia virus
|
more |
|
PKS |
IFO50421 |
pig |
kidney
|
susceptible to Vaccinia virus
|
more |
|
PL-21 |
JCRB1319 |
human |
hemo-lymphocytic
|
leukemia, acute promyelocytic
|
more |
| *7) |
PL502 |
JCRB1125 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL505 |
JCRB1128 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL507 |
JCRB1130 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL508 |
JCRB1194 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL512 |
JCRB1229 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL514 |
JCRB1300 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL516 |
JCRB1302 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL518 |
JCRB1307 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
| *7) |
PL532 |
JCRB1219 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from placenta, limited life span
|
more |
|
PLC/PRF/5 |
JCRB0406 |
human |
liver, gallbladder
|
hepatoma, HBs antigen-positive
|
more |
| *1) |
Pso-1 |
JCRB0641 |
human |
*****
|
*****
|
more |
| *1) |
Pso-2 |
JCRB0642 |
human |
*****
|
*****
|
more |
| *1) |
Pso-3 |
JCRB0643 |
human |
*****
|
*****
|
more |
| *1) |
Pso-4 |
JCRB0644 |
human |
*****
|
*****
|
more |
| *1) |
Pso-5 |
JCRB0645 |
human |
*****
|
*****
|
more |
| *1) |
Pso-6 |
JCRB0646 |
human |
*****
|
*****
|
more |
| *1) |
Pso-7 |
JCRB0647 |
human |
*****
|
*****
|
more |
| *5) |
PSV811 |
JCRB0604 |
human |
skin
|
Werner's syndrome fibroblast, SV40-infected, contamination by WI-38 was suspected.
|
more |
|
Pt K1 |
JCRB9039 |
marsupial (potoroo, rat kangaroo) |
kidney
|
kidney
|
more |
|
Pt K2 |
IFO50012 |
marsupial (potoroo, rat kangaroo) |
kidney
|
kidney, epithelial-like
|
more |
|
Pt K2 |
JCRB0007 |
marsupial (potoroo, rat kangaroo) |
kidney
|
DNA replication study
|
more |
|
Pt K2 (NBL-5) |
JCRB9052 |
marsupial (potoroo, rat kangaroo) |
kidney
|
kidney
|
more |
|
Py-3Y1-S2 |
JCRB0736 |
rat |
embryo
|
3Y1 derivative, mouse polyoma virus-transformed, (Fischer rat)
|
more |
|
Q |
Page Top |
|
|
|
|
|
QGP-1 |
JCRB0183 |
human |
pancreas
|
pancreatic islat cell carcinoma (somatostatinoma)
|
more |
|
R |
Page Top |
|
|
|
|
|
R201C |
JCRB1199 |
mouse |
skin
|
deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
|
more |
|
R2C |
JCRB9055 |
rat |
testis
|
Leydig cell testicular tumor,steroid secreting
|
more |
| *2) |
Ra-1 |
JCRB1313 |
rabbit |
hemo-lymphocytic
|
Rabbit lymphocyte cell line transformed with HTLV-I. HTLV-I-positive. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
|
Raji |
IFO50046 |
human |
hemo-lymphocytic
|
lymphoma, Burkitt's
|
more |
|
RAJI |
JCRB9012 |
human |
hemo-lymphocytic
|
lymphoma, Burkitt's
|
more |
|
Ramos(RA1) |
JCRB9119 |
human |
hemo-lymphocytic
|
lymphoma, Burkitt's (EBV negative)
|
more |
|
Ran Nor |
JCRB9079 |
human |
skin
|
osteoporosis, skin
|
more |
|
RAT-2 |
IFO50282 |
rat |
embryo
|
thymidine kinase deficient RAT-1 (F2408) cell line, (Fischer rat)
|
more |
| *2) |
RB16KY |
JCRB0311 |
human |
skin
|
fibroblast from retinoblastoma(13q-) patient
|
more |
| *2) |
RB24KY |
JCRB0312 |
human |
skin
|
fibroblast from retinoblastoma (bilateral) patient
|
more |
| *2) |
RB28KY |
JCRB0313 |
human |
skin
|
fibroblast from retinoblastoma (unilateral) patient
|
more |
|
RBL-1 |
IFO50034 |
rat |
hemo-lymphocytic
|
leukemia, basophilic (Wister rat)
|
more |
| *2) |
RBL162T |
JCRB0328 |
human |
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
|
more |
| *2) |
RBL182T |
JCRB0330 |
human |
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
|
more |
| *2) |
RBL221T |
JCRB0329 |
human |
hemo-lymphocytic
|
lymphoblastoid, from patient with hereditary disease with high cancer risk retinoblastoma (chromosome 13-deletion)
|
more |
|
RBL-2H3 |
JCRB0023 |
rat |
hemo-lymphocytic
|
leukemia, basophlic, mast cell line (Wistar rat)
|
more |
|
RC1 |
IFO50466 |
mouse |
antibody-producing hybridoma
|
RC1 antibody, recognizing undifferentiated neural cell-specific antigen
|
more |
|
RC-1 |
JCRB0246 |
rabbit |
cornea
|
cornea, (white rabbit)
|
more |
|
RC-K8 |
JCRB1334 |
human |
hemo-lymphocytic
|
lymphoma, malignant
|
more |
|
RCM-1 |
JCRB0256 |
human |
rectum
|
adenocarcinoma, well differentiated
|
more |
|
RCN-9 |
JCRB0167 |
rat |
colon
|
DMH induced colonic cancer, (F344/DuCrj rat)
|
more |
|
RCR-1 |
JCRB0129.1 |
rat |
neural
|
astrocyte-like cells, GFAP-positive
|
more |
|
RCR-1.P3 |
JCRB0129.0 |
rat |
neural
|
astrocyte-like cells, GFAP-positive, serum-free
|
more |
|
RD |
JCRB9072 |
human |
sarcoma
|
rhabdomyosarcoma, embryonal
|
more |
|
RERF-GC-1B |
JCRB1009 |
human |
stomach
|
adenocarcinoma
|
more |
|
RERF-LC-Ad1 |
JCRB1020 |
human |
lung (cancer)
|
adenocarcinoma
|
more |
|
RERF-LC-Ad2 |
JCRB1021 |
human |
lung (cancer)
|
adenocarcinoma
|
more |
|
RERF-LC-FM |
JCRB0102 |
human |
lung (cancer)
|
small cell carcinoma, intermediate
|
more |
|
RERF-LC-KJ |
JCRB0137 |
human |
lung (cancer)
|
adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes
|
more |
| *5) |
RERF-LC-MA |
JCRB0812 |
human |
lung (cancer)
|
small cell carcinoma, exhibits the same DNA profile as lung squamous carcinoma cell line SK-MES-1. (distribution is suspended)
|
more |
|
RERF-LC-MS |
JCRB0081 |
human |
lung (cancer)
|
adenocarcinoma
|
more |
| *5) |
RERF-LC-OK |
JCRB0811 |
human |
lung (cancer)
|
adenocarcinoma, (distribution is suspended)
|
more |
|
RERF-LC-Sq1 |
JCRB1019 |
human |
lung (cancer)
|
squamous carcinoma
|
more |
|
RI-T |
JCRB1088 |
rat |
liver
|
hepatic stellate cell line immortalized with SV40 T antigen, [mycoplasma-positive] (Wistar rat)
|
more |
|
RKN |
IFO50317 |
human |
ovary
|
leiomyosarcoma
|
more |
|
RKN |
JCRB0176 |
human |
ovary
|
leiomyosarcoma
|
more |
|
RL-33 |
JCRB0131 |
rabbit |
lung
|
HSV,VSV sensitive, suitable for study anti-viral agents
|
more |
|
RL-34 |
JCRB0247 |
rat |
liver
|
normal, collagen-induced growth arrest, (Wistar rat)
|
more |
|
RLC-10.P3 |
JCRB0718 |
rat |
liver
|
normal liver, RLC-10 derivative, no serum required, (JAR-1 rat)
|
more |
|
RLC-10.P3 |
JCRB0718.1 |
rat |
liver
|
normal liver, RLC-10 derivative, no serum required, deposited directly by original developer (JAR-1 rat)
|
more |
|
RLN-10 |
JCRB0415 |
rat |
liver
|
normal liver, (Donryu rat)
|
more |
|
RLN-8 |
JCRB0414 |
rat |
liver
|
normal liver, (Donryu rat)
|
more |
|
RLN-B2 |
JCRB0402 |
rat |
liver
|
normal liver, (Donryu rat)
|
more |
|
RLN-J-5-2 |
JCRB0407 |
rat |
liver
|
normal liver, (Donryu rat)
|
more |
|
RMG-I |
IFO50315 |
human |
ovary
|
clear cell carcinoma
|
more |
|
RMG-I |
JCRB0172 |
human |
ovary
|
mesonephroid adenocarcinoma
|
more |
| *1) |
RMG-II |
IFO50316 |
human |
ovary
|
mesonephroid cancer, (excluded from catalogue)
|
more |
|
RMG-II |
JCRB0172.1 |
human |
ovary
|
mesonephroid adenocarcinoma
|
more |
|
RMT-1 E4 |
JCRB0242 |
rat |
mammary
|
mammary carcinoma, dimethylbenzathracene induced, (SD rat)
|
more |
|
RMT-1 M2 |
JCRB0245 |
rat |
mammary
|
mammary myoepithelial cell, dimethylbenzathracene induced, (SD rat)
|
more |
| *5) |
RMUG-L |
IFO50319 |
human |
ovary
|
mucinous cystadenocarcinoma, (distribution is suspended, possibilty for cross-contamination with SNG-II)
|
more |
|
RMUG-S |
IFO50320 |
human |
ovary
|
mucinous cystadenocarcinoma
|
more |
|
RNB |
IFO50491 |
rat |
neural
|
astrocyte, GFAP-positive, (Wistar rat)
|
more |
|
RP-1 |
JCRB0195 |
mouse |
antibody-producing hybridoma
|
anti-rat neutrophil, IgG1
|
more |
|
RP-3 |
JCRB0196 |
mouse |
antibody-producing hybridoma
|
anti-rat neutrophil, IgM
|
more |
|
RPMI 1788 |
IFO50037 |
human |
hemo-lymphocytic
|
established from normal blood, IgM secreting
|
more |
|
RPMI 1788 |
JCRB0035 |
human |
hemo-lymphocytic
|
established from normal blood, IgM secreting
|
more |
|
RPMI 1846 |
JCRB9087 |
hamster, Syrian |
melanoma
|
melanotic melanoma
|
more |
|
RPMI 2650 |
JCRB9058 |
human |
nasal septum
|
quasi-diploid squamous carcinoma
|
more |
|
RPMI 8226 |
IFO50013 |
human |
hemo-lymphocytic
|
myeloma, multiple
|
more |
|
RPMI 8226 |
JCRB0034 |
human |
hemo-lymphocytic
|
myeloma, multiple
|
more |
|
RS-A |
JCRB0423 |
rat |
spleen
|
spleen, spontaneously transformed cells, (Donryu rat)
|
more |
|
RSMG-1 |
JCRB1146 |
rat |
submandibular gland
|
submandibular gland-derived epithelial cell line, (Wistar rat)
|
more |
| *5) |
RTSG |
IFO50318 |
human |
ovary
|
adenocarcinoma, poorly differentiated, (distribution is suspended, possiblity for cross-contamination with SNG-II)
|
more |
|
S |
Page Top |
|
|
|
|
|
S.CET.M8.1.1 |
JCRB0011 |
mouse |
antibody-producing hybridoma
|
anti-11-deoxycortisol, IgG
|
more |
|
SAS |
JCRB0260 |
human |
oral
|
squamous carcinoma, tongue
|
more |
|
SAT |
JCRB1027 |
human |
oral
|
squamous carcinoma, oral cavity
|
more |
| *5) |
SBC-1 |
JCRB0816 |
human |
lung (cancer)
|
small cell carcinoma, intermediate, JCRB0816 SBC-1 and JCRB0817 SBC-2 exhibit the same DNA profile. (distribution is suspended)
|
more |
| *5) |
SBC-2 |
JCRB0817 |
human |
lung (cancer)
|
small cell carcinoma, intermediate, JCRB0816 SBC-1 and JCRB0817 SBC-2 exhibit the same DNA profile. (distribution is suspended)
|
more |
|
SBC-3 |
JCRB0818 |
human |
lung (cancer)
|
small cell carcinoma, oat cell type
|
more |
|
SBC-5 |
JCRB0819 |
human |
lung (cancer)
|
small cell carcinoma, intermediate
|
more |
|
SC78.H81.C81.A9 |
JCRB1301 |
mouse |
antibody-producing hybridoma
|
anti-scopolamine antibody-producing. IgG1(k)
|
more |
|
SCC-131 |
JCRB0230 |
rat |
squamous cell carcinoma
|
squamous cell carcinoma
|
more |
|
SCC-158 |
JCRB0231 |
rat |
squamous cell carcinoma
|
squamous cell carcinoma
|
more |
|
SCC-3 |
JCRB0115 |
human |
hemo-lymphocytic
|
lymphoma, monocytic, non-Hodgkin's
|
more |
|
SCC-4 |
JCRB9118 |
human |
oral
|
squamous carcinoma, tongue
|
more |
|
SCCH-196 |
JCRB0108 |
human |
sarcoma
|
small round cell sarcoma
|
more |
|
SCCH-26 |
JCRB0106 |
human |
neural
|
neuroblastoma
|
more |
|
SCH |
JCRB0251 |
human |
stomach
|
choriocarcinoma arising at stomach from male patient
|
more |
| *4) |
SEKI |
JCRB0620 |
human |
melanoma
|
malignant melanoma (not available)
|
more |
|
SF126 |
IFO50286 |
human |
neural
|
glioblastoma multiforme, GFAP-negative
|
more |
|
SF-TY |
JCRB0075 |
human |
skin
|
normal fibroblast
|
more |
|
Shay |
JCRB0241 |
rat |
hemo-lymphocytic
|
granurocytic sarcoma, (Wister rat)
|
more |
|
SHOK |
IFO50367 |
hamster, Syrian |
embryo
|
fibroblast, contact-inhibited
|
more |
| *2) |
Si-1 |
JCRB1369 |
monkey, Japanese macaque |
hemo-lymphocytic
|
Japanese monkey lymphocyte line transformed with HTLV-I. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
| *2) |
Si-2 |
JCRB1321 |
monkey, Japanese macaque |
hemo-lymphocytic
|
STLV-I carrying Japanese monkey lymphoid cell line. (This cell line is supplied from National Institute of Biomedical Innovation.)
|
more |
|
SIRC |
IFO50020 |
rabbit |
cornea
|
susceptible to rubella virus
|
more |
|
SIRC |
JCRB9122 |
rabbit |
cornea
|
susceptible to rubella virus
|
more |
|
SJK-237-71 |
JCRB9032 |
mouse |
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
|
more |
|
SKG-I |
IFO50308 |
human |
uterine cervix
|
cervical epidermoid carcinoma
|
more |
|
SKG-II |
IFO50309 |
human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
|
more |
| *1) |
SKG-II |
JCRB0171 |
human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type (excluded from catalogue)
|
more |
|
SKG-IIIa |
IFO50310 |
human |
uterine cervix
|
cervical epidermoid carcinoma, clear cell type
|
more |
|
SKG-IIIa |
JCRB0232 |
human |
uterine cervix
|
cervical epidermoid carcinoma, clear cell type
|
more |
|
SKG-IIIb |
IFO50311 |
human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
|
more |
|
SKG-IIIb |
JCRB0232.1 |
human |
uterine cervix
|
cervical epidermoid carcinoma, large cell, non-keratinizing type
|
more |
|
SKM-1 |
JCRB0118 |
human |
hemo-lymphocytic
|
myelo dysplastic syndrome
|
more |
| *5) |
SK-MG-1 |
IFO50344 |
human |
neural
|
astrocytoma, adapted to serum-free medium, derived from Marcus cells, (distribution is suspended)
|
more |
|
SKN |
IFO50314 |
human |
uterus
|
leiomyosarcoma
|
more |
|
SKN |
JCRB0173 |
human |
uterus
|
leiomyosarcoma
|
more |
|
SKN-3 |
JCRB1039 |
human |
oral
|
squamous carcinoma, oral cavity
|
more |
|
SKNO-1 |
JCRB1170 |
human |
hemo-lymphocytic
|
leukemia, acute myeloblastic, GM-CSF dependent
|
more |
|
SLVL |
JCRB0159 |
human |
hemo-lymphocytic
|
lymphoma, splenic, B cell line with cytoplasmic villi
|
more |
|
SNG-II |
IFO50312 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
| *1) |
SNG-II |
JCRB0175 |
human |
uterus
|
endometrial adenocarcinoma, (excluded from catalogue)
|
more |
|
SNG-M |
IFO50313 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
SNG-M |
JCRB0179 |
human |
uterus
|
endometrial adenocarcinoma
|
more |
|
Sp2/O-Ag14 |
JCRB9084 |
mouse |
hemo-lymphocytic
|
myeloma, non-secreting, 8-azaguanine resistant
|
more |
|
SR-3Y1-2 |
JCRB0742 |
rat |
embryo
|
3Y1 derivative, transformed by Rous sarcoma virus, (Fischer rat)
|
more |
|
STC 1 |
JCRB1053 |
human |
lung (cancer)
|
small cell carcinoma
|
more |
|
STK1 |
JCRB9033 |
mouse |
antibody-producing hybridoma
|
anti-DNA polymerase alpha, IgG1
|
more |
|
SUIT-2 |
JCRB1094 |
human |
pancreas
|
pancreatic cancer, moderately differentiated tubular adenocarcinoma
|
more |
|
SV |
JCRB1207 |
mouse |
skin
|
SV40-immortalized fibroblast line from beta-galactosidase-deficient mouse
|
more |
|
SV-3Y1-C66 |
JCRB0735 |
rat |
embryo
|
3Y1 derivative, SV40-transformed, (Fischer rat)
|
more |
|
SV-T2 |
JCRB9099 |
mouse |
embryo
|
SV40 virus-transformed BALB/3T3, (BALB/c mouse)
|
more |
|
SVts-8 |
JCRB0506.1 |
human |
lung
|
fetal lung, immortalized fibroblast transfected with ts SV40 early gene, derivative of TIG-3 cells
|
more |
|
SW-13 |
JCRB9069 |
human |
adrenal cortex
|
adenocarcinoma
|
more |
|
SW837 |
JCRB9115 |
human |
rectum
|
adenocarcinoma
|
more |
|
T |
Page Top |
|
|
|
|
|
T.T |
JCRB0262 |
human |
esophagus
|
squamous carcinoma
|
more |
|
T.Tn |
JCRB0261 |
human |
esophagus
|
squamous carcinoma, established through nude mice transplant
|
more |
|
T-23 clone 8 |
JCRB0745 |
tupaia |
lung
|
normal, applicable for the mutation assay system in vitro
|
more |
|
T24 |
JCRB0711 |
human |
bladder
|
urinary bladder carcinoma
|
more |
|
TaD-1 |
IFO50112 |
rat |
thymus
|
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
|
more |
|
TaD-1-3 |
IFO50120 |
rat |
thymus
|
thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
|
more |
|
T-Ag-MOSE |
JCRB0151 |
mouse |
ovary
|
ovarian surface epithelial cell line immortalized by SV40 large T antigen, (C3H/He mouse)
|
more |
|
Takigawa |
JCRB0124 |
human |
stomach
|
gastric carcinoma, proliferates very slowly (D.T.=2 weeks).
|
more |
|
TALL-1 |
JCRB0086 |
human |
hemo-lymphocytic
|
leukemia, acute T lymphoblastic
|
more |
|
TASK1 |
JCRB0139 |
human |
neural
|
neuroectodermal tumor
|
more |
|
TCC-PAN2 |
JCRB1072 |
human |
pancreas
|
pancreatic cancer
|
more |
|
TCO-1 |
JCRB0239 |
human |
thyroid
|
non differentiated cancer
|
more |
|
TG1 |
JCRB0626 |
hamster, Chinese |
lung
|
V79 derivative, 6-thioguanine-resistant
|
more |
|
TGW |
JCRB0618 |
human |
neural
|
neuroblastoma, adrenal gland
|
more |
|
TGW.P3 |
JCRB0618.1 |
human |
neural
|
neuroblastoma, adrenal gland, serum-free
|
more |
|
THP-1 |
JCRB0112 |
human |
hemo-lymphocytic
|
leukemia, acute monocytic
|
more |
|
THP-1 |
JCRB0112.1 |
human |
hemo-lymphocytic
|
leukemia, acute monocytic
|
more |
|
TIG-101 |
JCRB0526 |
human |
skin
|
skin, normal diploid fibroblast (growth is slow)
|
more |
|
TIG-102 |
JCRB0527 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-103 |
JCRB0528 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
| *3) |
TIG-104 |
JCRB0529 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
| *3) |
TIG-105 |
JCRB0530 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
| *3) |
TIG-106 |
JCRB0531 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-107 |
JCRB0532 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-108 |
JCRB0537 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-109 |
JCRB0538 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-110 |
JCRB0543 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-111 |
JCRB0541 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-112 |
JCRB0533 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-113 |
JCRB0539 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-114 |
JCRB0534 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-118 |
JCRB0535 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-119 |
JCRB0540 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-120 |
JCRB0542 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-1-20 |
JCRB0501 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20
|
more |
|
TIG-121 |
JCRB0536 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-1-30 |
JCRB0502 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 30
|
more |
|
TIG-1-40 |
JCRB0503 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 40
|
more |
|
TIG-1-50 |
JCRB0504 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 50
|
more |
|
TIG-1-60 |
JCRB0505 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-1, PDL=about 60
|
more |
|
TIG-2M-30 |
JCRB0525 |
human |
muscular system
|
muscle, normal diploid fibroblast (not myoblast), PDL=about 30
|
more |
|
TIG-3-20 |
JCRB0506 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 20
|
more |
| *3) |
TIG-3-30 |
JCRB0507 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 30
|
more |
| *3) |
TIG-3-40 |
JCRB0508 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 40
|
more |
| *4) |
TIG-3-50 |
JCRB0509 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 50
|
more |
| *3) |
TIG-3-60 |
JCRB0510 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-3, PDL=about 60
|
more |
|
TIG-3S |
JCRB0544 |
human |
skin
|
skin, normal diploid fibroblast
|
more |
|
TIG-7-20 |
JCRB0511 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 20
|
more |
| *4) |
TIG-7-30 |
JCRB0512 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 30
|
more |
| *4) |
TIG-7-40 |
JCRB0513 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 40
|
more |
| *4) |
TIG-7-50 |
JCRB0514 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 50
|
more |
| *4) |
TIG-7-60 |
JCRB0515 |
human |
lung
|
fetal lung, normal diploid fibroblast, TIG-7, PDL=about 60
|
more |
|
TK |
JCRB0157 |
human |
hemo-lymphocytic
|
lymphoma, malignant, B-cell
|
more |
|
TK |
JCRB1206 |
human |
hemo-lymphocytic
|
lymphoma, malignant (arising at brain). This cell line is different from JCRB0157 TK.
|
more |
| *5) |
TK-1 |
JCRB0128 |
human |
neural
|
glioblastoma multiforme, contamination by U-251 MG was suspected
|
more |
|
TKC2 |
IFO50373 |
mouse |
kidney
|
tubule cell, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
more |
|
TKD2 |
IFO50374 |
mouse |
vascular system
|
endothelial cell, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
more |
|
TLR2 |
IFO50379 |
mouse |
liver
|
hepatocyte, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
more |
|
TLR3 |
IFO50380 |
mouse |
liver
|
hepatocyte, tsSV40 large T-immortalized, (C57BL/6 transgenic mouse)
|
more |
|
TMD5 |
IFO50516 |
human |
hemo-lymphocytic
|
leukemia, acute B lymphoblastic, double Philadelphia chromosomes
|
more |
|
TMH-1 |
JCRB1078 |
human |
thyroid
|
thyroid anaplastic carcinoma,(contamination by IHH-4 is suspected.)
|
more |
|
ts85 |
JCRB0705 |
mouse |
mammary
|
FM3A derivative, defective in ubiquitin activating enzyme, (C3H mouse)
|
more |
|
tsFT101 |
JCRB0706 |
mouse |
mammary
|
FM3A derivative, cytokinesis is blocked at 39 C, (C3H mouse)
|
more |
|
tsJT16 |
JCRB0153.2 |
rat |
embryo
|
3Y1-derivative, ts mutation for cell cycle progression from G0 and G1 to S phase, (Fischer rat)
|
more |
|
tsJT60 |
JCRB0153.3 |
rat |
embryo
|
3Y1-derivative, ts mutant cell line with cell cycle arrest at G0 phase, (Fischer rat)
|
more |
|
tsJT663 |
JCRB0153.1 |
rat |
embryo
|
3Y1-derivative, ts mutation for cell cycle progression from G1 to S phase, (Fischer rat)
|
more |
|
TuD-1 |
IFO50103 |
rat |
thymus
|
thymic stroma, keratin-positive, (ACI rat)
|
more |
|
TuD-1-3 |
IFO50152 |
rat |
thymus
|
thymic stroma, keratin-positive, (ACI rat)
|
more |
|
Ty-82 |
JCRB1330 |
human |
thymus
|
undifferentiated thymic carcinoma
|
more |
|
TYK-nu |
JCRB0234.0 |
human |
ovary
|
undifferentiated carcinoma
|
more |
|
TYK-nu.CP-r |
JCRB0234.1 |
human |
ovary
|
undifferentiated carcinoma, cisplatin-resistant
|
more |
|
U |
Page Top |
|
|
|
|
|
U-251 MG |
IFO50288 |
human |
neural
|
astrocytoma, GFAP-positive
|
more |
|
U-251 MG (KO) |
IFO50285 |
human |
neural
|
astrocytoma, GFAP-positive
|
more |
|
U937 |
JCRB9021 |
human |
hemo-lymphocytic
|
lymphoma, diffuse histiocytic, monocyte-like characteristics
|
more |
|
U-937 |
IFO50038 |
human |
hemo-lymphocytic
|
lymphoma, diffuse histiocytic, monocyte-like characteristics
|
more |
|
U937 cl1-14 |
JCRB0116.1 |
human |
hemo-lymphocytic
|
lymphoma, histiocytic, highly susceptible clone of U937 for HIV
|
more |
|
U937 cl1-22 |
JCRB0116.2 |
human |
hemo-lymphocytic
|
lymphoma, histiocytic, low susceptible clone of U937 for HIV
|
more |
|
UBE6T-15 |
JCRB1159 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
|
more |
|
UBE6T-6 |
JCRB1140 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
|
more |
|
UBE6T-7 |
JCRB1143 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT, HPV E6, bmi-1-introduced, immortalized
|
more |
| *7) |
UC701 |
JCRB1218 |
human |
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
|
more |
| *7) |
UC702 |
JCRB1220 |
human |
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
|
more |
| *7) |
UC704 |
JCRB1224 |
human |
umbilical cord
|
normal umbilical cord-derived cells with fibroblastic morphology, limited life span
|
more |
| *7) |
UCB302MSCs |
JCRB1106 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, limited life span, (growth is very slow.)
|
more |
| *7) |
UCB408E6E7-31 |
JCRB1108 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, HPV E6, E7-introduced, limited life span
|
more |
|
UCB408E6E7TERT-33 |
JCRB1110 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, hTERT and HPV E6, E7-introduced, immortalized
|
more |
| *7) |
UCB408E7-32 |
JCRB1109 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, HPV E7-introduced, limited life span
|
more |
|
UCBTERT-21 |
JCRB1107 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from umbilical cord blood, hTERT-immortalized
|
more |
| *7) |
UE6E7-16 |
JCRB1160 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, HPV E6, E7-introduced, limited life span
|
more |
|
UE6E7T-11 |
JCRB1149 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
more |
|
UE6E7T-12 |
JCRB1151 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
more |
|
UE6E7T-2 |
JCRB1133 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
more |
|
UE6E7T-3 |
JCRB1136 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E6, E7-introduced, immortalized
|
more |
|
UE7T-13 |
JCRB1154 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E7-introduced, immortalized
|
more |
|
UE7T-9 |
JCRB1147 |
human |
mesenchymal stem cell
|
mesenchymal stem cells from bone marrow, hTERT and HPV E7-introduced, immortalized
|
more |
|
V |
Page Top |
|
|
|
|
|
V79 |
JCRB0603 |
hamster, Chinese |
lung
|
fibroblast
|
more |
|
V79 379A |
IFO50082 |
hamster, Chinese |
lung
|
lung, fibroblast, widely used in somatic genetics
|
more |
|
V79 HPRT~ |
JCRB0707 |
hamster, Chinese |
lung
|
V79 derivative, HPRT-deficient
|
more |
|
V79-6TG |
JCRB0219 |
hamster, Chinese |
lung
|
6-thioguanine-resistant V79 cell line
|
more |
|
Vero |
IFO50471 |
monkey, African green |
kidney
|
useful to assay mycoplasmas
|
more |
|
VERO |
JCRB0111 |
monkey, African green |
kidney
|
normal, contact inhibited
|
more |
|
VERO |
JCRB9013 |
monkey, African green |
kidney
|
normal, contact inhibited
|
more |
|
VERO 76 |
IFO50410 |
monkey, African green |
kidney
|
normal, contact inhibited, lower saturation density than the original Vero
|
more |
|
VERO 76 |
JCRB9007 |
monkey, African green |
kidney
|
normal, contact inhibited, lower saturation density than the original Vero
|
more |
|
VMRC-LCD |
JCRB0814 |
human |
lung (cancer)
|
adenocarcinoma
|
more |
|
VMRC-LCP |
JCRB0103 |
human |
lung (cancer)
|
squamous cell carcinoma
|
more |
|
VMRC-MELG |
JCRB0074 |
human |
melanoma
|
malignant melanoma, colon
|
more |
|
VMRC-RCW |
JCRB0813 |
human |
kidney
|
renal cell carcinoma
|
more |
|
VMRC-RCZ |
JCRB0827 |
human |
kidney
|
renal carcinoma
|
more |
|
W |
Page Top |
|
|
|
|
|
WB-F344 |
JCRB0193 |
rat |
liver
|
liver epithelial cell line, reported as oval cell-like, (Fischer F344 rat)
|
more |
|
WEHI-3 |
JCRB9093 |
mouse |
hemo-lymphocytic
|
leukemia, myelomonocytic, macrophage-like, (BALB/c mouse)
|
more |
|
WEHI-3b |
IFO50296 |
mouse |
hemo-lymphocytic
|
myelomonocyte, (BALB/c mouse)
|
more |
|
WI-26 VA4 |
JCRB9042 |
human |
lung
|
fetal lung, SV40 virus transformed, derivative of WI-26
|
more |
|
WI-38 |
IFO50075 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
| *1) |
WI-38 |
JCRB9017 |
human |
lung
|
fetal lung, normal diploid fibroblast
|
more |
|
WI-38 VA13 sub 2 RA |
JCRB9057 |
human |
lung
|
fetal lung, SV40 virus transformed, derivative of WI-38
|
more |
| *4) |
WI-38-30 |
JCRB0517 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 30, (not available)
|
more |
|
WI-38-40 |
JCRB0518 |
human |
lung
|
fetal lung, normal diploid fibroblast, PDL=about 40
|
more |
|
WiDr |
IFO50043 |
human |
colon
|
adenocarcinoma
|
more |
|
WiDr |
JCRB0224 |
human |
colon
|
adenocarcinoma
|
more |
|
WIL2-NS |
JCRB9063 |
human |
hemo-lymphocytic
|
B lymphocyte line, from patient with hereditary spherocytic anemia, non-immunoglobulin secreting variant
|
more |
|
WISH |
IFO50004 |
human |
HeLa-contaminant
|
originally established from amnion, HeLa-contaminated
|
more |
|
X |
Page Top |
|
|
|
|
|
XC |
IFO50017 |
rat |
sarcoma
|
RSV-induced sarcoma, useful for assay of murine leukemia virus, (Wistar rat)
|
more |
| *2) |
XP2OS(SV) |
JCRB0301 |
human |
skin
|
xeroderma pigmentosum (A), SV40 transformed
|
more |
| *2) |
XP2SA |
JCRB0305 |
human |
skin
|
xeroderma pigmentosum (variant type), fibroblast
|
more |
| *2) |
XP2YO(SV) |
JCRB0302 |
human |
skin
|
xeroderma pigmentosum (F), SV40 transformed
|
more |
| *2) |
XP35OS |
JCRB0304 |
human |
skin
|
xeroderma pigmentosum (A), fibroblast
|
more |
| *2) |
XP39OS |
JCRB0326 |
human |
skin
|
xeroderma pigmentosum (A), fibroblast
|
more |
|
XP39OSTERT |
JCRB1057 |
human |
skin
|
xeroderma pigmentosum (A), fibroblast, immortalized by hTERT
|
more |
| *2) |
XP3OS |
JCRB0303 |
human |
skin
|
xeroderma pigmentosum (A), fibroblast
|
more |
|
XP3OS(SVT) |
JCRB1055 |
human |
skin
|
xeroderma pigmentosum (A), fibroblast, immortalized by SV40 large T
|
more |
| *2) |
XP40OS |
JCRB0327 |
human |
skin
|
xeroderma pigmentosum (C), fibroblast
|
more |
|
XP40OSTERT |
JCRB1058 |
human |
skin
|
xeroderma pigmentosum (C), fibroblast, immortalized by hTERT
|
more |
| *2) |
XPEMB-1 |
JCRB0325 |
human |
skin
|
xeroderma pigmentosum (A), embryo fibroblast
|
more |
| *2) |
XPL15OS |
JCRB0307 |
human |
hemo-lymphocytic
|
xeroderma pigmentosum (A), lymphoblastoid
|
more |
| *2) |
XPL3KA |
JCRB0306 |
human |
hemo-lymphocytic
|
xeroderma pigmentosum (C), lymphoblastoid
|
more |
|
Y |
Page Top |
|
|
|
|
|
Y-1 |
JCRB9056 |
mouse |
adrenal cortex
|
adrenocortical tumor, steroid-secreting, (LAF1 mouse)
|
more |
|
Y3-Ag 1.2.3 |
JCRB9091 |
rat |
hemo-lymphocytic
|
myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat)
|
more |
|
YG10003 |
JCRB0119 |
hamster, Chinese |
lung
|
salmonella O-acetyltransferase gene introduced CHL cells
|
more |
|
YG10007 |
JCRB0120 |
hamster, Chinese |
lung
|
human monomorphic N-acetyltransferase gene introduced CHL cells
|
more |
|
YG10008 |
JCRB0121 |
hamster, Chinese |
lung
|
human polymorphic N-acetyltransferase gene transfected CHL cells
|
more |
|
YH-13 |
IFO50493 |
human |
neural
|
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant
|
more |
|
YKG-1 |
JCRB0746 |
human |
neural
|
glioblastoma
|
more |
|
YMB-1 |
JCRB0823 |
human |
mammary
|
breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
|
more |
|
YMB-1-E |
JCRB0825 |
human |
mammary
|
breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
|
more |
| *1) |
YSK |
JCRB0619 |
rat |
*****
|
*****
|
more |
| *7) |
Yub 10F |
JCRB1116 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub621b |
JCRB1112 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub621BMC |
JCRB1113 |
human |
mesenchymal stem cell
|
from polydactylous finger, bone marrow
|
more |
| *7) |
Yub621c |
JCRB1111 |
human |
mesenchymal stem cell
|
from polydactylous finger, cartilage
|
more |
| *7) |
Yub622 |
JCRB1114 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub623 |
JCRB1115 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub625 |
JCRB1155 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub631 |
JCRB1156 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub632 |
JCRB1157 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub633 |
JCRB1158 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub634 |
JCRB1161 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub635 |
JCRB1162 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub636 |
JCRB1169 |
human |
mesenchymal stem cell
|
from polydactylous finger, bone marrow
|
more |
| *7) |
Yub637b |
JCRB1163 |
human |
mesenchymal stem cell
|
from polydactylous finger, bone
|
more |
| *7) |
Yub637s |
JCRB1173 |
human |
mesenchymal stem cell
|
from polydactylous finger, skin
|
more |
| *7) |
Yub642 |
JCRB1172 |
human |
mesenchymal stem cell
|
from polydactylous finger
|
more |
| *7) |
Yub642b |
JCRB1174 |
human |
mesenchymal stem cell
|
from polydactylous finger, bone
|
more |
| *7) |
Yub642p |
JCRB1171 |
human |
mesenchymal stem cell
|
from polydactylous finger, periosteum
|
more |
|
Z- |
Page Top |
|
|
|
|
|
ZEN |
JCRB1311 |
mouse |
antibody-producing hybridoma
|
anti-zearalenone, IgG1(lambda)
|
more |